How do you start a home health agency business in 2027?

TL;DR: Starting a home health agency business in 2027 (a.k.a. Medicare-certified home health agency (HHA), skilled home care agency, post-acute home health, certified home health agency (CHHA), or clinical home-based skilled services provider) -- the Medicare-certified skilled home care provider delivering intermittent skilled nursing (RN/LPN), physical therapy (PT), occupational therapy (OT), speech-language pathology (SLP), medical social work (MSW), and home health aide (HHA/CNA) services to homebound Medicare beneficiaries with a skilled need under a physician-signed plan of care, paid through 60-day episodes via the Patient-Driven Groupings Model (PDGM, since January 2020) split into two 30-day payment periods with HHRG (Home Health Resource Group) case-mix adjustment and ~30-visit LUPA (Low Utilization Payment Adjustment) thresholds, governed by 42 CFR 484 Conditions of Participation and the OASIS-E (Outcome and Assessment Information Set) clinical assessment tool -- means navigating CMS-855A Medicare enrollment plus state Department of Health home health licensure plus CHAP/ACHC/TJC accreditation (CMS-deemed status) plus 17 states still operating Certificate of Need (CON) for home health plus the federal Florida/Illinois/Michigan/Texas moratoriums on new Medicare home health enrollment plus federal anti-fraud apparatus (DOJ + OIG + UPIC + ZPIC + TPE + RAC + HEAT strike forces) that has recovered $5B+ in home health False Claims Act settlements 2010-2024, and operating against a US universe of ~11,500 Medicare-certified home health agencies serving ~3.2M Medicare beneficiaries annually with average ~5 episodes per beneficiary year per CMS + MedPAC + NAHC + Partnership for Quality Home Healthcare -- capturing typical mature 500-patient-census home health agency revenue $10M-$18M and 8-15% EBITDA margins (compressed vs hospice due to PDGM 4-7% cuts 2024-2026 + behavioral adjustment + visit-based labor intensity) with named comps including LHC Group (UnitedHealth/Optum acquired April 2023 for $5.4B), Amedisys (NASDAQ: AMED -- Optum acquisition pending FTC review since 2023), Enhabit (NYSE: EHAB -- Encompass Health spinoff 2022, hospice + home health), Encompass Health (NYSE: EHC), AccentCare (Advent International), Aveanna Healthcare (NASDAQ: AVAH), BAYADA Home Health Care (PE/private), BrightSpring Health Services (NASDAQ: BTSG IPO 2024, Pharmerica + Adoration + ResCare combination), AccordCare, HouseWorks (Audax), Compassus (Audax + TowerBrook), Pennant Group (NASDAQ: PNTG -- Ensign spinoff), Elara Caring, CenterWell Home Health (Humana NYSE: HUM, formerly Kindred at Home), Trinity Health At Home, Interim HealthCare, Maxim Healthcare Services, VNS Health (NYC nonprofit), Visiting Nurse Service of New York, Visiting Nurse Association of America (VNAA) -- with PE/strategic consolidation that drove multiples from 8-12x EBITDA pre-Optum-era to a now-compressed 6-10x range as PDGM cuts + behavioral adjustment + HHVBP value-based purchasing + RN labor crisis + Optum-Amedisys FTC scrutiny + Medicare Advantage rate compression weigh on the space. The hardest part is PDGM behavioral adjustment + 2024-2026 rate cuts (4-7% cumulative) plus OASIS-E complexity plus HHVBP (Home Health Value-Based Purchasing) nationwide with payment adjustments of plus/minus 5% by 2025 escalating toward plus/minus 9% by 2028 plus federal moratoriums in FL/IL/MI/TX plus Medicare audit exposure (UPIC + TPE + RAC + OIG + DOJ qui tam $5B+ recovered 2010-2024) plus RN labor crisis ($75K-$110K with 40-55% turnover) plus referral concentration (hospital discharge planners + SNF step-down driving 40-60% of admits, losing 1-2 sources collapses census) plus hospital readmission penalty effects on referral patterns plus Optum dominance + antitrust concerns plus MA-side rate compression (~50% of Medicare lives now MA paying 60-85% of FFS rates), not the capital stack.

> ### 🎯 Bottom Line > - [Capital] $165K-$465K to STARTUP a new Medicare-certified home health agency in non-CON / non-moratorium states (working capital + license + accreditation + initial RN/PT/OT staff + payroll runway + OASIS-E-capable EMR + insurance); $465K-$1.4M for CON-state new entry plus consulting + competing applications; $1.4M-$7M to ACQUIRE existing operating Medicare-certified HHA with active Medicare provider number + ~200-700 patient census + accreditation + referral relationships (multiple of 0.6-1.2x annual revenue OR 5-9x EBITDA depending on payer mix + census + survey + audit history); expect 12-30 months for de novo CMS Medicare certification (CMS-855A application + state DOH license + accreditation survey + initial Medicare certification survey after first patient admission validating 42 CFR 484 CoP compliance) and 6-18 months for CHOW (change of ownership) acquisition with provisional billing; home health is dramatically lower capital than SNF/AL/MC because care is delivered in the patient's home rather than a purpose-built facility (only office + EMR + clinician fleet + DEA-compliant medication storage if applicable); critical caveat -- CMS imposes federal Medicare HHA enrollment moratoriums that have been in place at various times in Florida (Miami-Dade + Broward), Illinois (Chicago), Michigan (Detroit), and Texas (Dallas + Houston) since 2013 to combat fraud, forcing CHOW acquisition rather than de novo in those metros. > - [Margins] Mature stabilized 500-patient-census Medicare-certified HHA generates $10M-$18M annual revenue with 8-15% EBITDA margins ($800K-$2.7M EBITDA) -- meaningfully compressed vs hospice and SNF Part A because PDGM rate cuts (4-7% cumulative 2024-2026 including behavioral adjustment), HHVBP value-based payment adjustments (plus/minus 5% by 2025 toward plus/minus 9% by 2028), visit-based labor intensity (RN + PT/OT/SLP + HHA + MSW visits at $65-$120/visit clinician compensation), ~30-visit LUPA threshold risk (episodes below threshold paid per-visit rather than full HHRG case-mix episode payment = sharp revenue drop), and Medicare Advantage rate compression (~50% of Medicare lives now MA paying 60-85% of FFS rates); payer mix typically 70-85% traditional Medicare PDGM (~$2,038 base 30-day period rate FY2025 adjusted by HHRG case-mix and HHVBP) + 10-20% Medicaid HCBS waiver + Medicaid managed care + 5-15% Medicare Advantage + commercial + workers comp, with the LUPA (Low Utilization Payment Adjustment) threshold at ~30 visits per 30-day period (varies by HHRG) the critical operational hurdle preventing under-utilization revenue collapse. > - [Hardest part] PDGM behavioral adjustment + 2024-2026 rate cuts + OASIS-E complexity + HHVBP penalties + FL/IL/MI/TX moratoriums + Medicare audit exposure + RN labor crisis + referral concentration + Optum dominance, not occupancy demand -- CMS implemented PDGM January 2020 replacing the 60-episode HHPPS prospective payment system introducing 30-day payment periods + HHRG case-mix adjustment based on admission source (community vs institutional) + timing (early vs late) + clinical grouping + functional impairment + comorbidity adjustment + behavioral adjustment (CMS reduced base rates assuming agencies would change coding/visit behavior, which then triggered ongoing rate clawbacks negative 3.925% in CY2023, negative 2.890% in CY2024, negative 1.975% in CY2025, projected continued cuts in CY2026 totaling 4-7% cumulative), plus OASIS-E (effective January 2023 expanding from OASIS-D1) with 100+ assessment items scored at start of care + recertification + transfer + discharge driving HHRG payment + HHVBP quality + HHQRP reporting, plus HHVBP (Home Health Value-Based Purchasing) nationwide January 2023 with payment adjustments plus/minus 5% by CY2025 escalating toward plus/minus 9% by CY2028 based on Total Performance Score across 12 measures, plus federal Medicare HHA enrollment moratoriums in FL/IL/MI/TX preventing de novo entry in major metros, plus DOJ qui tam False Claims Act $5B+ recovered 2010-2024 (Amedisys $150M 2014, Kindred/Gentiva $125M cumulative, LHC $65M cumulative, Almost Family $9.4M, Maxim $150M, plus dozens of smaller settlements), plus RN labor crisis ($75K-$110K + 40-55% turnover + agency RN $85-$135/hour 2-3x premium), plus referral concentration (hospital discharge planners + SNF step-down driving 40-60% of admits, losing 1-2 sources collapses census), plus hospital readmission penalty effects (CMS HRRP penalizing hospitals for 30-day readmissions creates incentive for hospital discharge planners to select HHAs with low rehospitalization scores), plus Optum/UnitedHealth dominance (acquired LHC Group April 2023 for $5.4B + Amedisys acquisition pending FTC review since 2023 = potential combined ~$10B+ home health revenue under single insurer if FTC approves), plus MA-side rate compression (~50% of Medicare lives now MA paying home health agencies 60-85% of traditional Medicare PDGM rates with prior authorization friction).

A home health agency in 2027 is a Medicare-certified skilled home care provider delivering intermittent skilled nursing (RN/LPN), physical therapy (PT), occupational therapy (OT), speech-language pathology (SLP), medical social work (MSW), and home health aide (HHA/CNA) services to homebound Medicare beneficiaries with a skilled need under a physician-signed plan of care. Structurally distinct from non-medical home care / private duty (q9630 -- companion + ADL care, no Medicare, ~$32-$45/hour private pay or Medicaid HCBS waiver), hospice (q9656 -- terminal care, per-diem Medicare Hospice Benefit, IDT with chaplain/bereavement), palliative care (q9620 -- non-terminal symptom management, Part B physician fees), skilled nursing facility SNF (q9655 -- residential 24/7 RN-supervised), assisted living AL (q9650), memory care MC (q9653), adult day care ADC (q9652), LTACH/IRF (post-acute hospitals), inpatient rehab (rehab hospital), and PACE (Program of All-Inclusive Care for the Elderly -- Medicare/Medicaid integrated for nursing-home-eligible at home). Home health is uniquely episode-based paid under PDGM 30-day payment periods with HHRG case-mix adjustment + ~30-visit LUPA threshold + HHVBP value-based adjustment plus/minus 5% by 2025, requiring homebound status + skilled need + physician plan of care + face-to-face encounter within 90 days prior or 30 days after start of care.

The honest 2027 demand reality -- ~11,500 Medicare-certified home health agencies in the US serving ~3.2M Medicare beneficiaries annually with ~5 episodes per beneficiary year average per CMS Home Health Compare + MedPAC + NAHC + Partnership for Quality Home Healthcare. Demand drivers: 65+ population growing from ~58M (2024) to ~80M by 2040 per US Census Bureau; 75+ population growing from ~24M (2024) to ~45M by 2040; post-acute hospital discharge to home (vs SNF) growing as CMS + commercial payors incentivize lowest-cost-appropriate setting; chronic disease management at home (CHF, COPD, diabetes, post-surgical, wound care, IV therapy) growing; hospital-at-home (acute care at home) pilots expanding via CMS Acute Hospital Care at Home waiver extended through 2024 (then extended in 2025) creating adjacency; Medicare Advantage in-home assessments + supplemental benefits expanding (~50% of Medicare lives now MA); patient preference for aging at home over institutional care. Counter-demand pressures: PDGM behavioral adjustment + ongoing rate cuts compressing revenue per episode, HHVBP penalties for low quality scores, referral source consolidation (large hospital systems negotiating preferred-HHA panels), Medicare Advantage prior authorization + rate compression, federal moratoriums in FL/IL/MI/TX preventing de novo entry.

The five things that determine whether a Medicare home health operator survives years 1-3: (1) OASIS-E accuracy + HHRG case-mix optimization + clinical coding discipline -- OASIS-E assessment at start of care + recertification drives HHRG payment + HHVBP quality + HHQRP reporting; under-coding = revenue left on table, over-coding = audit exposure; (2) Referral pipeline -- hospital discharge planners + SNF step-down + community physicians + ACOs/MA plans -- 40-60% of admissions flow through 5-15 referral sources; losing 1-2 referral sources collapses census within 30-60 days; preferred-HHA panel inclusion at large hospital systems critical; (3) Visit-based clinician staffing model -- RN case manager (1:25 ratio) + PT/OT/SLP + HHA + MSW + per-visit pay $65-$120/visit -- managing clinician productivity (5-7 visits/day RN, 6-8 visits/day PT/OT, 6-8 visits/day HHA) + agency reduction toward <10% + retention toward 30-40% turnover (industry 40-55%); (4) HHVBP Total Performance Score + Star Rating on Care Compare -- 2023+ nationwide HHVBP with plus/minus 5% by 2025 escalating to plus/minus 9% by 2028; Star Rating (1-5 stars) on Care Compare drives referral preference + patient choice; (5) Medicare audit posture + LUPA discipline + PDGM accuracy -- UPIC + TPE + ADR + recoupment + DOJ qui tam exposure ($5B+ recovered 2010-2024); LUPA threshold at ~30 visits/30-day period determines whether episode paid full HHRG or per-visit (sharp revenue cliff); behavioral-adjustment-driven CMS rate cuts ongoing.

🗺️ Table of Contents

Part 1 -- Foundations

• [Market size & home health vs adjacent post-acute formats](#market-size--home-health-vs-adjacent-post-acute-formats)
• [CON + moratoriums + state DOH + CMS-855A + CHAP/ACHC/TJC accreditation + CoP licensing stack](#con--moratoriums--state-doh--cms-855a--chapachctjc-accreditation--cop-licensing-stack)
• [Business structure, ownership models & insurance](#business-structure-ownership-models--insurance)

Part 2 -- Build-Out & Capital

• [Startup economics & sub-market site selection](#startup-economics--sub-market-site-selection)
• [Clinical + EMR + OASIS-E + scheduling + billing software stack](#clinical--emr--oasis-e--scheduling--billing-software-stack)
• [Clinician staffing model & the RN labor crisis](#clinician-staffing-model--the-rn-labor-crisis)

Part 3 -- Operations

• [Referral pipeline -- hospital, SNF, ACO/MA, community](#referral-pipeline--hospital-snf-acoma-community)
• [PDGM 30-day periods, HHRG case-mix, LUPA & the rate cuts](#pdgm-30-day-periods-hhrg-case-mix-lupa--the-rate-cuts)
• [Medicare audits, qui tam DOJ, PEPPER & federal moratoriums](#medicare-audits-qui-tam-doj-pepper--federal-moratoriums)
• [HHQRP + OASIS-E + CAHPS + HHVBP value-based purchasing](#hhqrp--oasis-e--cahps--hhvbp-value-based-purchasing)

Part 4 -- Growth & Exit

• [Marketing, community education & referral cultivation](#marketing-community-education--referral-cultivation)
• [Scale milestones from 1 office to multi-state platform](#scale-milestones-from-1-office-to-multi-state-platform)
• [PE/strategic consolidation, Optum dominance & exit math](#pestrategic-consolidation-optum-dominance--exit-math)
• [Counter-case & risks](#counter-case--risks)

---

📐 PART 1 -- FOUNDATIONS

Market size & home health vs adjacent post-acute formats

A Medicare-certified home health agency in 2027 is a Medicare-certified skilled home care provider delivering care in patient's home (~100% of visits) to homebound Medicare beneficiaries with a skilled need under a physician-signed plan of care + face-to-face encounter requirement (within 90 days prior or 30 days after start of care). The US universe spans approximately ~11,500 Medicare-certified home health agencies serving ~3.2M Medicare beneficiaries annually per CMS Home Health Compare + MedPAC + NAHC (National Association for Home Care & Hospice). Industry consolidation: for-profit ~80% of HHAs (vs nonprofit ~10% + government ~10%) with PE-backed consolidators (LHC Group acquired by Optum/UnitedHealth April 2023 for $5.4B, Amedisys acquisition by Optum pending FTC review since 2023, Encompass/Enhabit spinoff 2022, AccentCare-Advent, BAYADA, BrightSpring NASDAQ BTSG IPO 2024, Aveanna NASDAQ AVAH, CenterWell Home Health/Humana from Kindred at Home acquisition 2018) driving market share growth. Patient census the dominant operating metric: small HHA <100 census, mid 100-500 census, large 500-2,500 census, mega 2,500+ census (CenterWell Home Health/Humana ~350,000+ patients annually, LHC ~300,000+, Amedisys ~300,000+).

Home health must be clinically distinguished from adjacent post-acute / home-based formats: (1) Non-medical home care / private duty (q9630 adjacent) -- companion + ADL assistance (bathing, dressing, toileting, meals, light housekeeping, transportation, medication reminders) delivered by non-medical caregivers (CNAs, HHAs without Medicare certification, companions); not Medicare-covered; private pay $32-$45/hour OR Medicaid HCBS waiver OR LTC insurance OR VA Aid & Attendance; minimal federal regulation (state-by-state licensure varies); BAYADA, Right at Home, Visiting Angels, Comfort Keepers, Home Instead Senior Care, Synergy HomeCare, BrightStar Care, Griswold Home Care dominant brands. (2) Hospice (q9656 adjacent) -- terminal end-of-life care delivered under Medicare Hospice Benefit (per-diem, 4 levels of care, ~$215/day RHC baseline); IDT including chaplain + bereavement + volunteer; 6-month-or-less prognosis. (3) Palliative care (q9620 adjacent) -- non-terminal serious illness symptom + pain management, often concurrent with curative treatment; Part B physician fees + facility fees. (4) Skilled nursing facility (SNF -- q9655) -- residential 24/7 RN-supervised post-acute or long-term care; Medicare Part A short-stay or Medicaid long-stay. (5) Inpatient rehab facility (IRF) -- specialty rehab hospital for intensive PT/OT/SLP post-stroke/post-surgery; Medicare Part A. (6) LTACH (long-term acute care hospital) -- specialty hospital for medically complex patients requiring 25+ day acute care; Medicare Part A. (7) Hospital-at-home (acute care at home) -- CMS Acute Hospital Care at Home waiver extended through 2024 (then extended 2025) allowing hospitals to deliver acute inpatient care at home with home-based clinicians + telehealth + remote monitoring; adjacent emerging format. (8) PACE (Program of All-Inclusive Care for the Elderly) -- Medicare/Medicaid integrated capitated program for nursing-home-eligible at home + ADC. (9) Home infusion therapy -- IV antibiotic, TPN, chemotherapy at home; Medicare Part B + DME supplier + nursing visits; often subcontracted to specialty home infusion providers (Option Care Health, CVS Coram, BriovaRx, BioScrip). (10) DME (durable medical equipment) home delivery -- hospital bed, wheelchair, oxygen, CPAP delivered to home; Medicare Part B DME supplier (Apria, Lincare, AdaptHealth, Rotech). (11) Home dialysis (peritoneal + home hemodialysis) -- ESRD treatment at home; ESRD-specific reimbursement; DaVita HomeFlex, Fresenius Kidney Care. (12) Telehealth + remote patient monitoring (RPM) -- adjacent virtual care delivery; Medicare reimbursement expanded post-COVID.

The home health revenue model rests on Medicare PDGM 30-day payment periods with HHRG case-mix adjustment, replacing the legacy HHPPS (Home Health Prospective Payment System) 60-day episode model effective January 2020. PDGM structure: each 60-day certification period split into two 30-day payment periods; each 30-day period grouped into one of 432 HHRG case-mix groups based on (a) Admission Source (community admit vs institutional admit from hospital/SNF/IRF/LTACH within prior 14 days), (b) Timing (early = first 30-day period in 60-day cert vs late = subsequent), (c) Clinical Grouping (12 clinical groups: MMTA-Other, MMTA-Cardiac/Circulatory, MMTA-Endocrine, MMTA-GI/GU, MMTA-Infectious, MMTA-Respiratory, MMTA-Surgical Aftercare, Behavioral Health, Complex Nursing Interventions, Musculoskeletal Rehabilitation, Neuro Rehabilitation, Wounds), (d) Functional Impairment Level (low/medium/high based on OASIS-E functional items), (e) Comorbidity Adjustment (no adjustment / low / high based on secondary diagnoses). FY2025 base 30-day payment rate ~$2,038 (varies by HHRG case-mix weight + wage index + HHVBP adjustment). LUPA (Low Utilization Payment Adjustment) threshold typically ~30 visits per 30-day period (varies 2-6 visits by HHRG group): episodes below threshold paid per-visit rate (~$185-$285/visit by discipline) rather than full HHRG case-mix episode payment = sharp revenue drop. Typical mature 500-patient-census HHA generates $10M-$18M annual revenue at 8-15% EBITDA margin ($800K-$2.7M EBITDA) -- compressed vs hospice/SNF Part A due to PDGM rate cuts + behavioral adjustment + visit-based labor + LUPA risk + HHVBP penalties + MA rate compression.

Dominant US home health operator names useful as benchmarks: LHC Group (acquired by Optum/UnitedHealth April 2023 for $5.4B, ~300,000+ patients annually, ~960 locations across 38 states) -- now operates under Optum Home Health umbrella, CenterWell Home Health (Humana NYSE: HUM, formerly Kindred at Home acquired by Humana 2018 then partial divestiture to Clayton Dubilier + TPG 2022 then reacquired by Humana 2022, ~350,000+ patients, ~750 locations across 38 states, largest US home health by census), Amedisys (NASDAQ: AMED, ~300,000+ patients annually, ~520 home health locations + hospice + personal care, Optum acquisition pending FTC review since 2023), Encompass Health Home Health and Hospice (was NYSE: EHC, spun off as Enhabit NYSE: EHAB 2022, ~250 home health locations + ~110 hospice locations across 34 states), AccentCare (Advent International PE-backed since 2019, ~245 home health locations + hospice + personal care, acquired Seasons Hospice 2020), Aveanna Healthcare (NASDAQ: AVAH, ~340 locations across 35 states, home health + hospice + private duty + pediatric), BAYADA Home Health Care (private/PE, ~390 locations across 23 states, home health + assistive care + hospice), BrightSpring Health Services (NASDAQ: BTSG IPO January 2024 at $13 per share raising $693M, ~10,000 service locations across 50 states, home health + hospice + pharmacy + personal care + facilities, combination of Pharmerica + Adoration Health + ResCare), Pennant Group (NASDAQ: PNTG, Ensign Group spinoff 2019, ~135 senior living + home health + hospice across 13 states), Compassus (Audax + TowerBrook PE-backed, ~250 locations across 30 states with Ascension Health JV, home health + hospice + palliative + infusion), Elara Caring (PE-backed, ~225 locations across 17 states, home health + hospice + personal care + behavioral health), HouseWorks (Audax-backed, regional Northeast home care + hospice), Trinity Health At Home (Trinity Health Catholic system home health + hospice + palliative service line ~50 locations across 10 states), Interim HealthCare (franchise, ~330 franchise locations nationwide), Maxim Healthcare Services (PE/private, home health + private duty + behavioral health), AccordCare (regional Southeast), Three Oaks Hospice & Home Health, VNS Health (NYC, formerly Visiting Nurse Service of New York, largest US nonprofit home + community health, ~46,000 patients daily across NYC), Visiting Nurse Association of America (VNAA, nonprofit federation), Bayshore HealthCare (Canadian + US), Help at Home (NASDAQ exit, home + community-based services), Addus HomeCare (NASDAQ: ADUS, home health + hospice + personal care). Industry structure: for-profit ~80% market share, nonprofit ~10%, government/hospital-based ~10%; PE consolidation aggressively rolling up regional HHAs but ~7,500-8,000 small/mid independent HHAs remain (consolidation runway substantial).

CON + moratoriums + state DOH + CMS-855A + CHAP/ACHC/TJC accreditation + CoP licensing stack

Home health faces a multi-layered federal CMS + state DOH + accreditation regulatory stack -- comparable to hospice in complexity but with the additional barrier of federal Medicare HHA enrollment moratoriums in Florida (Miami-Dade + Broward), Illinois (Chicago), Michigan (Detroit), and Texas (Dallas + Houston) that have been in place at various times since 2013 to combat fraud. The dominant stack a new operator must navigate:

(1) Federal Medicare HHA enrollment moratoriums -- CMS imposed temporary moratoriums on new Medicare HHA enrollments in Florida (Miami-Dade + Broward counties), Illinois (Chicago metro), Michigan (Detroit metro), and Texas (Dallas + Houston metros) beginning 2013 + extended multiple times + lifted in 2019 + partially reinstated 2020+ in selected areas; operators should verify current moratorium status via CMS Medicare Provider Enrollment + Chain Ownership System (PECOS) + CMS Moratoria Tool before applying for de novo enrollment. In moratorium markets, CHOW (change of ownership) acquisition of existing HHA is the only entry path. (2) Certificate of Need (CON) for home health -- 17 states still operate CON for home health including AL, CT, DC, GA, KY, MD, MS, NC, NJ, NY, NV, RI, SC, TN, VT, WV, WA (varies by year as states reform/repeal CON). CON application $15K-$125K legal + consulting + application fees, 6-18 month review process, public hearings, competing applications, success rates 25-55%. (3) State Department of Health (DOH) home health license -- every state requires state DOH or equivalent home health agency license; annual recertification + complaint surveys + change-of-ownership review; state DOH licensing fees $2K-$15K initial + $500-$3K annual. (4) CMS Form 855A Medicare Provider Enrollment -- institutional provider enrollment for Medicare home health; initial certification survey by state DOH on behalf of CMS validates compliance with 42 CFR 484 Conditions of Participation before Medicare provider number issued; first patient admission required before initial Medicare certification survey; typical 12-30 month process de novo from application to active Medicare provider number including state license + accreditation + CMS-855A + initial certification survey. CHOW (change of ownership) of existing HHA triggers new CMS provider number application + re-survey -- typical 60-180 day process with provisional billing during pendency. (5) Accreditation by CHAP / ACHC / TJC -- CMS deems accreditation by one of three approved accreditors equivalent to CMS certification survey: CHAP (Community Health Accreditation Partner) dominant home health + hospice accreditor, ACHC (Accreditation Commission for Health Care) second-largest, The Joint Commission (TJC) legacy hospital-focused with home care program. Accreditation $8K-$35K initial application + $5K-$15K annual with on-site survey every 3 years + interim self-assessment. (6) CMS Conditions of Participation 42 CFR 484 -- federal regulatory backbone covering Subpart A General Provisions (§484.1-§484.2), Subpart B Patient Care (§484.40 Release of patient identifiable OASIS information, §484.45 Reporting OASIS information, §484.50 Patient rights, §484.55 Comprehensive assessment of patients, §484.58 Discharge planning, §484.60 Care planning, coordination of services, quality of care, §484.65 Quality assessment and performance improvement -- QAPI, §484.70 Infection prevention and control, §484.75 Skilled professional services, §484.80 Home health aide services, §484.85 Personnel qualifications, §484.95 Training requirements), Subpart C Organizational Environment (§484.100 Compliance with federal, state, and local laws, §484.102 Emergency preparedness, §484.105 Organization and administration of services, §484.110 Clinical records, §484.115 Personnel qualifications), Subpart D Home Health Aide Services (§484.80), Subpart E Prospective Payment System (§484.200-§484.265 covering PDGM mechanics), Subpart F Conditions of Participation Outpatient PT/SLP (§484.300+), Subpart G Quality Reporting (§484.245). Annual standard survey by state DOH or accreditor validates compliance. (7) CMS Home Health Quality Reporting Program (HHQRP) -- mandatory quality reporting tied to Medicare payment; failure to report = 2% Medicare payment reduction. (8) OASIS-E (Outcome and Assessment Information Set version E) -- effective January 2023 expanding from OASIS-D1; 100+ assessment items scored at Start of Care + Resumption of Care + Recertification + Transfer to inpatient facility + Discharge; drives HHRG case-mix payment + HHVBP quality measures + HHQRP reporting + Star Rating on Care Compare; submitted electronically via CMS QIES (Quality Improvement and Evaluation System) ASAP. (9) CAHPS Home Health Survey (HHCAHPS) -- patient experience survey administered by CMS-approved CAHPS vendor; publicly reported on Care Compare; covers care of patients, communication with providers, specific care issues, overall rating, willingness to recommend. (10) HHVBP (Home Health Value-Based Purchasing) -- nationwide January 2023 (after 9-state pilot 2016-2022) with payment adjustments plus/minus 5% by CY2025 escalating toward plus/minus 9% by CY2028 based on Total Performance Score across 12 measures including OASIS-based outcomes (improvement in dyspnea, improvement in ambulation, improvement in bathing, improvement in management of oral medications) + claims-based outcomes (acute care hospitalization during first 60 days, emergency department use without hospitalization during first 60 days) + HHCAHPS measures + Discharge Function Score. (11) Star Rating on Care Compare -- composite 1-5 star rating publicly displayed driving patient + referral source choice. (12) Face-to-Face encounter requirement -- Medicare regulation since 2011 requires face-to-face encounter by physician or NP within 90 days prior or 30 days after start of care documenting homebound status + skilled need; missed F2F = payment denial. (13) Physician plan of care + signed orders + recertification every 60 days; missed cert = payment denial. (14) HIPAA + 42 CFR Part 2 -- full HIPAA + substance abuse confidentiality compliance + BAA business associate agreements. (15) DEA registration -- limited DEA registration if controlled substances managed (less common in home health than hospice). (16) Background checks + abuse registry -- every direct care employee criminal background check + state nurse aide abuse registry; CNA certification for HHAs.

(17) Pre-Claim Review / Review Choice Demonstration (RCD) -- CMS implemented Pre-Claim Review Demonstration in Illinois 2016 then expanded as Review Choice Demonstration (RCD) in IL, OH, NC, FL, TX allowing HHAs to choose between (a) pre-claim review (CMS reviews 100% of claims before submission), (b) post-payment review (UPIC reviews 100% of claims after payment with recoupment), (c) 25% pre-payment review with reduced scrutiny option after high performance. RCD designed to reduce Medicare home health fraud + improper payments. (18) Targeted Probe and Educate (TPE) -- MAC reviews 20-40 claims per round (up to 3 rounds) with education between rounds + recoupment if not improved. (19) Hospital Readmission Reduction Program (HRRP) effects -- CMS HRRP penalizes hospitals up to 3% of Medicare Part A payment for excess 30-day all-cause readmissions; hospital discharge planners increasingly select HHAs with low rehospitalization scores to reduce HRRP exposure = quality + Star Rating drive referral preference. (20) State-specific staffing + clinical requirements -- many states layer additional requirements on federal CoP (e.g. RN supervisory visit frequency, HHA competency evaluation cycle).

The disciplined new operator: hires Administrator + Director of Patient Care Services (DPCS, RN required) + healthcare regulatory counsel specialized in home health in target state before opening, retains CHAP/ACHC/TJC accreditation consultant for initial accreditation survey preparation, builds OASIS-E-trained clinical team + ICD-10 coding-trained billing + Medicare-experienced administrator + compliance officer + QAPI program + LUPA monitoring + HHVBP optimization + Star Rating monitoring + HHQRP reporting capability before opening, and treats OASIS-E accuracy + HHRG case-mix optimization + LUPA discipline + HHVBP performance + audit-ready compliance as highest operating priorities.

Business structure, ownership models & insurance

The dominant home health ownership structure in 2026 is for-profit LLC or corporation owned by founder/PE/strategic -- for-profit market share ~80% of Medicare-certified HHAs driven by PE consolidation (LHC/Optum, Amedisys, AccentCare-Advent, BAYADA, BrightSpring, Aveanna, CenterWell/Humana, Compassus, Elara Caring, Pennant). Alternative structures: (a) Nonprofit 501(c)(3) home health -- legacy community/faith-based + visiting nurse association model (VNS Health NYC, VNA federations, Trinity Health At Home Catholic system); (b) Hospital-affiliated home health -- health system operating home health as post-acute service line (Mayo Clinic Home Health, Cleveland Clinic Home Care, Kaiser Permanente Home Health, Sutter Home Health, Providence Home Services); (c) PE-backed for-profit platform (LHC + Amedisys + AccentCare + BAYADA + Compassus + Elara + Pennant + Aveanna + BrightSpring); (d) Strategic-owned (insurance + senior services integration) -- CenterWell/Humana, Optum/UnitedHealth (LHC + pending Amedisys); (e) Single-founder owner-operator -- nurse-founder / PT-founder / hospital-veteran-founder starting de novo HHA. Entity structure: standard pattern is single LLC (Delaware or state-specific) holds Medicare provider number + employs clinical staff + contracts with PT/OT/SLP/MSW contractors + holds vendor agreements. Working capital requirement notably lower than SNF but higher than hospice -- home health cash flow cycle 30-60 days with RAP (Request for Anticipated Payment) eliminated 2022 (RAPs historically provided 50-60% early cash but CMS eliminated to combat fraud); NOA (Notice of Admission) required within 5 days of start of care + final claim within 30-day period close; typical de novo HHA needs $165K-$465K operating capital to absorb pre-stabilization burn during 12-18 month census ramp.

Insurance stack (comparable to hospice -- lighter than SNF because home-care delivery + skilled-clinician documentation discipline): (1) Professional Liability (Med Mal) + General Liability -- combined PL + GL with limits typically $1M/$3M per claim/aggregate minimum, $2M/$5M-$3M/$10M preferred, $5M-$15M for multi-state operators; premium $25K-$185K annually per 500-census HHA (varies by state -- CA/FL/TX/NY/IL higher); key carriers include CNA HealthPro, MedPro Group (Berkshire Hathaway), ProAssurance (NYSE: PRA), The Doctors Company, Coverys, Beazley, AXA XL, AIG, Hiscox, Berkshire Hathaway Specialty, Markel, Distinguished Programs, Arthur J Gallagher, Marsh McLennan, USI, HUB International, Lockton, Newfront. (2) Workers Compensation -- HHAs classified under NCCI 8826 Home Health Care Skilled and Unskilled (same class code as hospice); premium $2.50-$6.50 per $100 of payroll (moderate-to-high WC rate driven by RN/PT/OT/HHA driving + patient handling + needle-stick); typical 500-census HHA with $5M-$8M payroll = $125K-$520K annual WC premium. (3) Auto / Hired & Non-Owned Auto -- HHA clinicians drive to patient homes (100% of visits are home visits); typically non-owned auto policy with $1M-$2M limit covering employee-owned vehicles used for HHA work; $10K-$55K annually for 500-census HHA with 30-60 clinicians driving; some HHAs provide mileage reimbursement at IRS rate (CY2025 ~$0.67/mile) rather than company vehicles. (4) Property + Business Interruption -- office space full replacement value with BI rider; $5K-$45K annually office-only. (5) Cyber Liability at $2M-$5M -- HIPAA breach + ransomware (HHAs major ransomware targets given PHI) -- $8K-$45K annually. (6) EPLI Employment Practices Liability at $1M-$3M -- RN/PT/OT turnover + clinician HR complaints = moderate EPLI exposure -- $8K-$25K annually. (7) Umbrella Liability at $5M-$25M -- multi-site HHAs routinely carry $10M-$50M umbrella -- $15K-$125K annually. (8) Sexual Abuse + Molestation sub-limit at $500K-$3M -- vulnerable elderly + isolated home setting -- $3K-$25K annually. (9) Crime / Employee Dishonesty at $250K-$1M -- protects against employee theft from patients (rare but real exposure in home visits) -- $2K-$8K annually. (10) Directors & Officers (D&O) at $1M-$5M -- $8K-$35K annually. (11) Pollution Liability -- covers medical waste (sharps + biohazard) -- $2K-$15K annually. (12) Bond + Surety -- required by some states for Medicare/Medicaid provider -- $1K-$5K annually. Total Year 1 insurance load for a 500-census HHA: $200K-$850K (premium urban high-litigation states $300K-$1.2M; multi-state platforms with SIR $1M-$5M aggregated). Contract discipline: every admission includes (a) Medicare home health notice + plan of care, (b) physician orders + face-to-face encounter documentation, (c) OASIS-E assessment, (d) HIPAA authorization, (e) financial responsibility (Medicare/Medicaid + any non-covered services), (f) Patient Rights notice + grievance procedure, (g) Advance Beneficiary Notice (ABN) if applicable, (h) photograph release.

---

🧱 PART 2 -- BUILD-OUT & CAPITAL

Startup economics & sub-market site selection

Home health startup capital is dramatically lower than SNF/AL/MC because care is delivered in patient's home (~100% of visits) rather than purpose-built facility. Five paths: (1) De novo Medicare-certified HHA in non-CON / non-moratorium state -- typical $165K-$465K startup capital covering office lease ($20K-$75K annual), CMS-855A + state DOH license ($5K-$25K), accreditation CHAP/ACHC/TJC ($15K-$45K initial), OASIS-E-capable EMR ($25K-$85K initial + $1K-$3K/mo subscription), startup clinical staff payroll runway 6-12 months ($85K-$285K), insurance Year 1 ($25K-$95K), legal + consulting ($25K-$85K), branding + website + initial marketing ($15K-$45K), miscellaneous (laptops + phones + clinical bags + initial supplies $25K-$65K). 12-30 months from application to active Medicare provider number + first patient admission before initial certification survey + census ramp 0-150 patients over 12-18 months. (2) De novo in CON state -- typical $465K-$1.4M startup capital including CON application $15K-$125K + CON consulting $50K-$185K + 12-18 month CON review with public hearings + competing applications + 25-55% success rate. (3) De novo in CMS moratorium state (FL/IL/MI/TX selected metros) -- NOT POSSIBLE during moratorium; CHOW acquisition is only entry path. (4) Acquire existing operating HHA (CHOW) -- typical $1.4M-$7M acquisition for 200-700-census HHA with active Medicare provider number + accreditation + referral relationships; multiples typically 0.6-1.2x annual revenue OR 5-9x EBITDA (depending on payer mix + census + survey + audit history + state + HHVBP score); CHOW 60-180 days with provisional billing risk during pendency; only path in moratorium markets. (5) Acquire + build (regional rollup) -- PE-backed strategy acquiring 2-5 existing HHAs in geographic concentration then organic growth + adjacent acquisition.

Office build-out -- typical 500-census HHA office 2,000-4,500 sqft in commercial office building with administrator office + DPCS office + clinical staff workstations + medication storage (limited Schedule II) + records storage (HIPAA-compliant) + IDT/team meeting room + reception + break room; rent $20K-$75K annual depending on metro; tenant improvements $30K-$165K. Sub-market selection criteria: (1) Medicare beneficiary density -- 65+ population in service area (typically 30-45 minute drive from office for clinical visit efficiency); minimum 25K-65K Medicare beneficiaries in catchment for 500-census viability; (2) Hospital + SNF + IRF discharge volume -- 3-8 acute care hospitals + 15-30 SNFs + 1-3 IRFs in service area producing referral pipeline; (3) Existing home health competition -- assess via CMS Care Compare + Home Health Compare + state DOH HHA list to understand competing supply, market saturation, dominant local operators; mature markets (FL, AZ, TX, CA) have 15-50+ HHAs competing for referrals; under-served rural markets may have 1-5 HHAs; (4) State Medicaid HCBS waiver + Medicaid managed care -- Medicaid HCBS waiver provides supplemental payer mix; state-by-state rates vary; (5) CON status -- CON state (AL/CT/DC/GA/KY/MD/MS/NC/NJ/NY/NV/RI/SC/TN/VT/WV/WA) substantially harder de novo entry; (6) Federal CMS moratorium status -- FL (Miami-Dade + Broward) / IL (Chicago) / MI (Detroit) / TX (Dallas + Houston) may have moratorium preventing de novo; (7) Labor market -- RN + LPN + PT + OT + SLP + HHA + MSW availability + wage benchmarks; tight labor markets squeeze margins; (8) HHVBP regional performance baseline -- check state-level HHVBP baseline to understand competitive quality bar; (9) MA penetration -- markets with high MA penetration (~50%+) face MA prior auth + rate compression. Working capital -- typical 500-census HHA needs $165K-$465K working capital at stabilization for 30-60 day Medicare A/R cycle + payroll + vendor payments (post-RAP-elimination Medicare cash cycle longer than pre-2022).

Clinical + EMR + OASIS-E + scheduling + billing software stack

Home health clinical/operating tech stack must support OASIS-E-capable EMR integrated with clinical assessment + plan of care + visit documentation + ICD-10 coding + HHRG case-mix + LUPA monitoring + Medicare claims processing (NOA + final claim + PDGM) + scheduling + visit verification + EVV (Electronic Visit Verification for Medicaid) + HHQRP/HHVBP/CAHPS quality reporting + family/patient portal + telehealth + RPM remote patient monitoring -- substantially specialized for home health workflow distinct from hospice + SNF. The dominant home health platforms in 2025-2026:

(1) Homecare Homebase (Hearst Health-owned) -- dominant home health + hospice EMR/platform with ~30%+ home health market share including LHC Group, Amedisys, Compassus, Pennant Group, HouseWorks, BAYADA; full clinical EMR + OASIS-E + IDT + plan of care + scheduling + claims + RCM; pricing $185-$385 per census per month all-in; hchb.com. (2) MatrixCare Home Health and Hospice (ResMed-owned) -- major home health EMR (also dominant in SNF); pricing $145-$285 per census per month; matrixcare.com. (3) WellSky Home Health (formerly Kinnser, Mediware/WellSky-owned) -- dominant mid-market home health EMR; wellsky.com. (4) Axxess Home Health -- home health EMR for mid-market; axxess.com. (5) KanTime Home Health -- pediatric + adult home health EMR; kantime.com. (6) HCSS (Home Care Software Solutions) -- home health EMR + scheduling; hcsslink.com. (7) Alora Home Health -- mid-market home health EMR; alorahealth.com. (8) NetSmart Home Care -- behavioral health + senior care + home health clinical platform; netsmarttech.com. (9) Brightree Home Health (ResMed-owned) -- home health EMR + intake; brightree.com. (10) HEALTHCAREfirst -- home health + hospice EMR; healthcarefirst.com. (11) MEDsys Home Care -- home care EMR; medsyshcs.com. (12) Forcura -- workflow + intake + clinical document management for home health + hospice; forcura.com. (13) PointClickCare Home and Community Care -- PointClickCare home care module (PointClickCare dominant in SNF); pointclickcare.com. (14) Devero Home Health (HHAeXchange-owned) -- home health EMR; devero.com. (15) AppHealthCare -- home health EMR for small/mid; apphealthcare.com.

OASIS-E is the critical clinical assessment tool under 42 CFR 484.45 -- effective January 2023 expanding from OASIS-D1 with 100+ items scored at Start of Care (SOC), Resumption of Care (ROC), Recertification (every 60 days), Transfer to inpatient facility, Discharge from agency; OASIS-E added standardized assessment items for transfer of health information + social determinants of health + cognitive function + behavioral health screening; submitted electronically via CMS QIES (Quality Improvement and Evaluation System) ASAP; drives HHRG case-mix payment + HHVBP quality measures + HHQRP reporting + Star Rating on Care Compare. OASIS-E accuracy is the dominant clinical operating discipline -- under-coding leaves revenue on the table, over-coding triggers UPIC audit + recoupment + qui tam exposure. Sophisticated HHAs invest in OASIS-E certification training for all RNs + dedicated OASIS-E coding review staff (QA reviewer reviewing every OASIS before submission) + ICD-10 coding expertise + HHRG case-mix optimization + LUPA monitoring tools.

EVV (Electronic Visit Verification) -- federal 21st Century Cures Act mandate required EVV for Medicaid personal care services by January 1, 2020 and Medicaid home health services by January 1, 2023 with potential 1% federal Medicaid funding reduction for non-compliant states; EVV verifies (a) type of service performed, (b) individual receiving service, (c) date of service, (d) location of service delivery, (e) individual providing service, (f) time service begins and ends. Major EVV vendors: HHAeXchange (largest Medicaid EVV vendor), Sandata Technologies, Tellus (eMedNY), CareBridge, Therap Services, AuthentiCare, Mobile Caregiver+, regional state-specific aggregators. Most home health EMRs integrate EVV natively.

Telehealth + Remote Patient Monitoring (RPM) -- adjacent technology expanding home health capability: RPM for CHF (weight + BP + heart rate) + COPD (SpO2 + dyspnea) + diabetes (glucose) + post-surgical (wound photos + symptoms) delivered via Bluetooth-enabled devices + tablet/phone; CMS Medicare Part B RPM CPT codes 99453/99454/99457/99458 reimbursable; vendors: Health Recovery Solutions (largest home health RPM platform), Vivify Health, Welltok, Validic, CareSignal, AlayaCare, Tactio Health, GE Healthcare, Philips, Cardiocom. Telehealth for medical director consult + virtual visit (limited Medicare reimbursement post-COVID expansion partially extended).

Billing + revenue cycle management -- Medicare home health claims processing including NOA within 5 days + final claim within 30-day period close + PDGM HHRG billing + LUPA monitoring + ADR response + Medicare appeal: Homecare Homebase RCM, MatrixCare RCM, WellSky RCM, McKesson, Optum Insight, Change Healthcare (UnitedHealth), Waystar, AthenaCollector, Net Health, RCM Health Care Services, Cantata Health, Allevia, Healthpac, regional home health RCM specialists. LUPA monitoring -- critical Medicare home health compliance + revenue optimization function; specialty tools help operators monitor LUPA risk in real-time and adjust visit patterns to avoid LUPA payment cliff.

Accounting: Sage Intacct, NetSuite, MS Dynamics 365 for multi-state platforms; QuickBooks Online + ADP/Paychex payroll for single-site. HR/payroll: ADP, Paychex, Paylocity, UKG (Kronos), Smartlinx, Workday. Scheduling: many HHAs use EMR-integrated scheduling (Homecare Homebase, MatrixCare, WellSky) for clinician visit management; some use OnShift, Smartlinx, ABILITY SmartForce. CRM / referral tracking + intake: Forcura, Trella Health, Playmaker Health (Trella-owned), Axxess CRM, Salesforce Health Cloud, HubSpot, custom CRM -- critical for tracking 5-15 referral sources + intake conversion + referral attribution. HHQRP + HHVBP reporting: OASIS-E + HHCAHPS + claims-based measures automated via EMR with quarterly + annual CMS submission.

Total Year 1 tech stack cost for 500-census HHA: $185K-$485K annually all-in (EMR + scheduling + CRM + billing/RCM + EVV + RPM + accounting + payroll + HHQRP).

Clinician staffing model & the RN labor crisis

Staffing is 45-58% of home health P&L (similar to hospice but with PT/OT/SLP therapy heavy) and dominant pressure point with RN labor crisis (40-55% home health RN turnover, $75K-$110K home health RN wages, contract agency RN $85-$135/hour). Home health CoP under 42 CFR 484 mandates skilled professional services + home health aide services + qualified personnel. The dominant 500-census home health staffing model:

For 500-census HHA, total clinical + leadership + BD + business office staff = ~50-85 FTE (PT/OT/SLP often per-visit contracted reducing FTE count; depends on visit volume + therapy mix). Per-visit clinician pay -- common alternative to W-2 salary: RN $65-$120/visit, PT/OT/SLP $65-$120/visit, PTA/COTA $40-$70/visit, HHA $25-$45/visit, MSW $65-$100/visit; per-visit model shifts volume risk to clinician + reduces fixed cost. Contract agency reality -- HHA RN/PT/OT/HHA contract agency at $85-$135/hour vs $75K-$110K core wage = 2-3x premium; agency use varies by market (urban tight markets 10-20% of nursing labor, mid-market 5-10%, rural 2-5%). Disciplined HHA operators focus on RN pipeline + retention (sign-on bonuses $5K-$15K, retention bonuses $2K-$10K, predictable visit-based scheduling, home health-experience premium $3K-$10K above general RN, career ladder to OASIS-E coder + clinical manager + DPCS, mileage reimbursement IRS rate ~$0.67/mile CY2025, productivity bonuses for hitting visits/day targets), productivity benchmarks (RN case manager 5-7 visits/day, PT/OT 6-8 visits/day, HHA 6-8 visits/day, MSW 3-4 visits/day with phone support), agency reduction toward <10%, turnover toward 30-40% (still high but better than 55%+).

---

⚙️ PART 3 -- OPERATIONS

Referral pipeline -- hospital, SNF, ACO/MA, community

Home health referral pipeline is the dominant operational reality -- 40-60% of admissions flow through 5-15 key referral sources with home health liaisons / community liaisons (HHA-employed BD reps embedded with referral sources) as primary BD function. Losing 1-2 major referral sources can collapse census within 30-60 days. The referral channels for home health admissions:

(1) Hospital discharge planners + case managers + hospitalists (PRIMARY -- 40-60% of admits) -- every acute care hospital has discharge planning department + case management; home health liaisons build relationships with discharge planners + case managers + attending physicians + hospitalists + physical therapists + hospital readmission reduction teams. Daily morning rounds presence + same-day response + accept difficult admits + 24-48 hour SOC (start of care) + maintain low rehospitalization scores (Star Rating + HHVBP) + clinical capability + responsive communication are the operational disciplines that win referral share. Hospital Readmission Reduction Program (HRRP) drives hospital preference for HHAs with low 30-day readmission scores -- quality + Star Rating + HHVBP performance directly drive referral share. Hospital preferred-HHA panels -- large hospital systems (HCA, Tenet, Ascension, CommonSpirit, Trinity Health, Providence, AdventHealth, Cleveland Clinic, Mayo Clinic, Kaiser Permanente, Sutter, Banner, Atrium, Northwell, NYU Langone) maintain preferred-HHA lists with 3-7 HHAs; competitive contract + quality demonstration earn inclusion.

(2) SNF + IRF step-down (15-25% of admits) -- patients transitioning from SNF or IRF to home receive home health for continued skilled care; SNF social workers + discharge planners refer; HHA liaisons cultivate relationships with 15-30 SNFs + 1-3 IRFs in service area.

(3) Community physicians + primary care + specialists (10-20% of admits) -- PCPs + cardiologists + endocrinologists + pulmonologists + orthopedic surgeons + wound care specialists refer patients with skilled need (post-surgical, chronic disease, wound care, IV therapy, diabetic teaching); cultivate physician relationships through CME + clinical updates + responsive communication.

(4) ACO (Accountable Care Organization) + Medicare Shared Savings Program (MSSP) -- ACOs incentivized to manage Medicare beneficiary costs increasingly use home health as low-cost-appropriate setting; HHA preferred-provider arrangements with ACO networks.

(5) Medicare Advantage plans + insurance case managers (5-15% of admits, growing) -- MA plan case managers + commercial insurance case managers refer with prior authorization; ~50% of Medicare lives now MA driving increasing MA-side referral volume; MA prior auth + rate compression friction is real challenge.

(6) Outpatient surgery centers + ambulatory care (3-7% of admits) -- ambulatory surgery centers + outpatient procedures generate post-surgical home health referrals (wound care, drain management, post-op recovery).

(7) Wound care centers + specialty clinics (2-5% of admits) -- specialty wound care centers refer complex wound patients for home wound care.

(8) Adult day care + senior services + community organizations (1-3% of admits) -- ADC + senior centers + Area Agency on Aging + faith-based community generate occasional referrals.

(9) Family / community direct admits (2-5% of admits) -- direct family inquiry via website + community education + word-of-mouth + caregiver referrals.

(10) Hospital-at-home programs + acute hospital care at home (emerging) -- CMS Acute Hospital Care at Home waiver-participating hospitals partner with HHAs for hospital-at-home clinical delivery; emerging adjacent referral channel.

(11) Home infusion + DME suppliers (1-3% of admits) -- home infusion therapy + DME suppliers refer patients needing skilled nursing coordination.

(12) VA + Indian Health Service + Tribal referrals -- VA Community Care Network + IHS + tribal health programs refer veterans + Native Americans.

(13) PACE + Programs of All-Inclusive Care for the Elderly -- PACE programs occasionally refer for skilled home health beyond PACE scope.

Admission cycle: (a) Referral receipt (referral source sends referral with clinical history, hospital discharge summary, recent labs/imaging, attending physician info, medication list), (b) Clinical eligibility review by intake RN (assess Medicare home health eligibility -- homebound status + skilled need + physician plan of care + face-to-face encounter within 90 days prior or 30 days after SOC), (c) Insurance verification + Medicare home health benefits eligibility check, (d) Start of Care (SOC) visit by RN case manager within 24-48 hours of referral -- comprehensive OASIS-E assessment + plan of care development + medication reconciliation + physician orders confirmation + patient/family education + clinical visit scheduling, (e) Plan of care signed by physician + sent to physician for signature within 30 days + Notice of Admission (NOA) submitted within 5 days to CMS, (f) Initial clinical visits by RN + PT/OT/SLP as ordered + HHA visits + MSW visits + telehealth/RPM setup if indicated + patient/family education + 60-day certification cycle begins. The disciplined HHA runs 24-48 hour SOC (faster = higher referral share), same-day-of-referral response, clinical capability to accept complex admits (wound care, IV therapy, complex behavioral, pediatric if equipped, complex chronic disease), low rehospitalization scores driving Star Rating + HHVBP, and maintained census growth toward 500+ patients.

PDGM 30-day periods, HHRG case-mix, LUPA & the rate cuts

The Patient-Driven Groupings Model (PDGM) is the economic foundation of Medicare home health -- replaced the legacy HHPPS (Home Health Prospective Payment System) 60-day episode model effective January 1, 2020. PDGM was designed to shift home health payment from therapy-volume-driven (which incentivized over-utilization of PT/OT visits) to patient-need-driven (which incentivizes clinical complexity + functional impairment + comorbidity coding accuracy). The PDGM structure:

Episode + payment period structure: Medicare home health is delivered in 60-day certification periods (with physician recertification required every 60 days) but paid in two 30-day payment periods per 60-day cert; agency files one final claim per 30-day payment period.

HHRG case-mix grouping: each 30-day payment period grouped into one of 432 HHRG (Home Health Resource Groups) case-mix groups based on five variables: (1) Admission Source -- community admit (patient lived in community prior 14 days, no acute hospital/SNF/IRF/LTACH stay) vs institutional admit (patient discharged from acute hospital/SNF/IRF/LTACH within prior 14 days, higher case-mix weight reflecting greater clinical complexity); (2) Timing -- early (first 30-day payment period within 60-day cert, higher case-mix weight) vs late (subsequent 30-day payment periods, lower case-mix weight reflecting CMS view that acute-phase intensity declines over time); (3) Clinical Grouping -- 12 clinical groups based on primary diagnosis: MMTA-Other (Medication Management Teaching and Assessment), MMTA-Cardiac/Circulatory, MMTA-Endocrine, MMTA-GI/GU, MMTA-Infectious, MMTA-Respiratory, MMTA-Surgical Aftercare, Behavioral Health, Complex Nursing Interventions, Musculoskeletal Rehabilitation, Neuro Rehabilitation, Wounds; clinical group weight varies (Wounds + Complex Nursing typically higher, Behavioral Health typically lower); (4) Functional Impairment Level -- low / medium / high based on OASIS-E functional items (grooming, current dressing upper body, current dressing lower body, current bathing, toileting hygiene, transferring, ambulation, eating, prior functioning); higher impairment = higher case-mix weight; (5) Comorbidity Adjustment -- no adjustment / low / high based on secondary diagnoses (specific ICD-10 codes for diabetes, CHF, CKD, dementia, etc.); higher comorbidity = higher case-mix weight. Total possible HHRG combinations: 2 admission sources × 2 timings × 12 clinical groups × 3 functional levels × 3 comorbidity = 432 groups.

FY2025 base 30-day payment rate ~$2,038 (FY2025 base $2,037.65 with wage index adjustment + HHRG case-mix weight + HHVBP adjustment). Average HHA collects $1,500-$2,800 per 30-day payment period depending on case-mix mix.

LUPA (Low Utilization Payment Adjustment): episodes with fewer than the LUPA threshold visits in a 30-day payment period are paid per-visit (~$185-$285/visit by discipline) rather than full HHRG case-mix episode payment. LUPA threshold varies by HHRG group from 2 to 6 visits (CMS sets threshold at 10th percentile of visit count for each HHRG); typical operational threshold ~3-4 visits. LUPA is the dominant operational risk -- episodes below threshold generate ~30-60% less revenue than full HHRG payment; disciplined HHAs monitor LUPA risk in real-time + adjust visit patterns to push episodes above threshold (without unnecessary visits). Average LUPA % industry-wide: 7-10% of 30-day periods; target LUPA % <5% for disciplined operators.

PDGM Behavioral Adjustment + ongoing rate cuts (2024-2026): CMS implemented PDGM with a behavioral adjustment of -4.36% in 2020 assuming agencies would change coding/visit behavior (more institutional-source coding, more early-period coding, more comorbidity coding) to inflate payments; CMS then monitored actual coding behavior and found agencies did adjust coding upward, triggering ongoing rate clawbacks: negative 3.925% in CY2023, negative 2.890% in CY2024, negative 1.975% in CY2025, with projected continued cuts in CY2026 totaling 4-7% cumulative rate reduction. Industry advocates (NAHC + Partnership for Quality Home Healthcare) lobbying CMS + Congress to reverse behavioral adjustment cuts; CMS reduced cumulative cuts from initial proposals through stakeholder feedback.

Sequential billing + NOA discipline -- Medicare home health requires Notice of Admission (NOA) submitted within 5 calendar days of Start of Care (replaced RAP Request for Anticipated Payment in 2022 -- RAPs historically provided 50-60% early cash but CMS eliminated to combat fraud); missed NOA = 1/30 daily payment reduction for each day late from SOC to NOA receipt. Final claim filed at end of each 30-day payment period.

Medicare Advantage home health rate compression -- ~50% of Medicare lives now MA; MA plans pay home health agencies 60-85% of traditional Medicare PDGM rates with prior authorization + visit limits + utilization management; MA-side rate compression is dominant margin pressure as MA penetration grows. Some MA plans contract via percent-of-PDGM (60-85%) others via per-visit rates ($95-$165/visit) others via capitation.

Medicare audits, qui tam DOJ, PEPPER & federal moratoriums

Medicare audit + DOJ qui tam False Claims Act + PEPPER + federal moratoriums are the largest single existential risks for home health operators -- DOJ has recovered $5B+ in home health False Claims Act settlements 2010-2024. Major named cases: (a) Amedisys -- $150M settlement 2014 for OASIS over-coding + therapy over-utilization + ineligible patients; (b) Kindred Healthcare / Gentiva -- $125M+ cumulative settlements for therapy over-utilization + ineligible patients (Kindred at Home was acquired by Humana 2018 then partial divest 2022 then reabsorbed 2022 as CenterWell Home Health); (c) LHC Group -- $65M+ cumulative settlements (LHC acquired by Optum/UnitedHealth April 2023); (d) Almost Family -- $9.4M settlement 2017; (e) Maxim Healthcare Services -- $150M settlement 2011 for over-billing; (f) ResCare -- multiple settlements; (g) numerous smaller settlements $2M-$50M range; (h) ongoing qui tam (whistleblower) FCA cases filed by former employees + nurses + therapists under seal with potential 15-30% relator share of settlements driving plaintiff bar interest.

Federal home health audit + enforcement apparatus:

(1) UPIC (Unified Program Integrity Contractor) -- CMS-contracted audit contractor performing post-payment review of Medicare home health claims flagged by data analytics + complaints + referral; can request medical records via ADR (Additional Documentation Request) and recoupment if claims unsupported. Major UPICs: CGI Federal (Northeast), Performant Recovery (Midwest), SafeGuard Services (Southeast + West), AdvanceMed (West).

(2) ZPIC (Zone Program Integrity Contractor) -- predecessor to UPIC, still referenced in legacy contracts.

(3) TPE (Targeted Probe and Educate) -- MAC-run program reviewing 20-40 claims per round (up to 3 rounds), providing education between rounds, with MAC referral to UPIC + recoupment if not improved. Major MACs for home health: Palmetto GBA (JM), CGS Administrators (JN), National Government Services (J6, JK), Noridian (JE, JF), Novitas Solutions (JL, JH).

(4) RAC (Recovery Audit Contractor) -- contingency-fee audit contractor reviewing claims for over-payment.

(5) OIG (Office of Inspector General -- HHS) -- federal investigative + audit arm performing Work Plan audits + Compliance Program reviews + Corporate Integrity Agreements (CIA) post-settlement; OIG publishes annual Work Plan identifying home health audit priorities (OASIS over-coding, therapy over-utilization, ineligible patients, homebound status, face-to-face encounter, plan of care).

(6) DOJ (Department of Justice) -- federal criminal + civil prosecution; DOJ qui tam False Claims Act actions filed under seal by whistleblowers with potential 15-30% relator share; DOJ has recovered $5B+ in home health FCA 2010-2024.

(7) HEAT (Health Care Fraud Prevention and Enforcement Action Team) -- joint DOJ + HHS strike force focused on Medicare fraud in Miami, Houston, Detroit, Los Angeles, Brooklyn, Tampa, Chicago, Dallas with home health major target driving FL/IL/MI/TX federal moratoriums.

(8) PEPPER (Program for Evaluating Payment Patterns Electronic Report) -- TMF Health Quality Institute-prepared comparative analytics report distributed quarterly to every Medicare home health agency. PEPPER reports each HHA's percentiles vs national/state peers on home-health-specific outlier indicators: (a) Average Case Mix, (b) Episodes with 5 or 6 Therapy Visits, (c) High Therapy Episodes (≥20 visits), (d) Average Visits per Episode, (e) Hospitalization rate, (f) Outlier Payments, (g) Non-LUPA Episodes, (h) LUPA Episodes. Hospitals in 80th+ percentile (or 20th percentile for under-utilization) face elevated audit risk + recommended internal review + potential UPIC referral.

(9) Pre-Claim Review / Review Choice Demonstration (RCD) -- CMS implemented Pre-Claim Review Demonstration in Illinois 2016 then expanded as Review Choice Demonstration (RCD) in IL, OH, NC, FL, TX with three choice options: (a) 100% pre-claim review, (b) 100% post-payment review, (c) 25% pre-payment review with reduced scrutiny option after high performance.

(10) Federal Medicare HHA enrollment moratoriums -- CMS imposed temporary moratoriums on new Medicare HHA enrollments in FL (Miami-Dade + Broward), IL (Chicago), MI (Detroit), TX (Dallas + Houston) beginning 2013 + extended multiple times + lifted 2019 + partially reinstated 2020+ in selected areas; operators verify current status via CMS PECOS + Moratoria Tool.

(11) OASIS-E accuracy + ICD-10 coding scrutiny -- OASIS-E over-coding (functional impairment + comorbidity coding driving up HHRG case-mix weight) + ICD-10 coding errors are dominant audit flags; sophisticated HHAs invest in OASIS-E QA reviewer + ICD-10 certified coders.

(12) Homebound status documentation -- Medicare requires patient be homebound (confined to home with normal inability to leave home + requires considerable + taxing effort + occasional absences for medical/non-medical reasons allowed); homebound status documentation must be in clinical record + face-to-face encounter; insufficient documentation = audit flag.

(13) Face-to-Face encounter documentation -- Medicare requires face-to-face encounter by physician or NP within 90 days prior or 30 days after SOC; documentation must support homebound + skilled need; missing or inadequate F2F = payment denial.

(14) Compliance program + corporate integrity -- sophisticated HHAs maintain OIG-compliant compliance program (written policies + training + monitoring + reporting + investigation + enforcement), internal OASIS-E QA review + ICD-10 coding audit + LUPA monitoring + PEPPER review + HHVBP review (quarterly minimum), internal medical record audit + eligibility validation, whistleblower reporting hotline + non-retaliation policy, OIG Exclusion List monthly screening (no excluded individuals can work for Medicare provider), CIA (Corporate Integrity Agreement) compliance if applicable post-settlement.

The audit + qui tam + moratorium exposure is the dominant financial + reputational risk in home health -- sophisticated operators treat compliance + OASIS-E accuracy + LUPA discipline + HHVBP optimization as the highest operational priority above growth.

HHQRP + OASIS-E + CAHPS + HHVBP value-based purchasing

Home Health Quality Reporting Program (HHQRP) is mandatory CMS quality reporting; failure to report = 2% Medicare payment reduction. Four components:

(1) OASIS-E (Outcome and Assessment Information Set version E) -- effective January 2023 expanding from OASIS-D1 with 100+ items scored at Start of Care (SOC), Resumption of Care (ROC), Recertification (every 60 days), Transfer to inpatient facility, Discharge from agency; OASIS-E added standardized assessment items for transfer of health information + social determinants of health + cognitive function + behavioral health screening; submitted electronically via CMS QIES (Quality Improvement and Evaluation System) ASAP; drives HHRG case-mix payment + HHVBP quality measures + HHQRP reporting + Star Rating on Care Compare.

(2) HHCAHPS (Home Health Consumer Assessment of Healthcare Providers and Systems Survey) -- patient experience survey administered by CMS-approved CAHPS vendor (NRC Health, Press Ganey, Strategic Healthcare Programs SHP, Deyta Analytics, HEALTHCAREfirst CAHPS, Fazzi Associates); 34 questions across 3 composite measures: Care of Patients, Communication Between Providers and Patients, Specific Care Issues + 2 global rating measures (overall rating 0-10 + willingness to recommend); publicly reported on Care Compare quarterly.

(3) Claims-based outcome measures -- CMS calculates from Medicare claims data: (a) Acute Care Hospitalization During First 60 Days of Home Health, (b) Emergency Department Use Without Hospitalization During First 60 Days of Home Health, (c) Discharge to Community, (d) Medicare Spending Per Beneficiary (MSPB).

(4) HHVBP (Home Health Value-Based Purchasing) -- nationwide January 2023 (after 9-state pilot 2016-2022) with payment adjustments plus/minus 5% by CY2025 escalating toward plus/minus 9% by CY2028 based on Total Performance Score across 12 measures: OASIS-based outcomes (Improvement in Dyspnea, Improvement in Ambulation, Improvement in Bathing, Improvement in Management of Oral Medications, Discharge Function Score), claims-based outcomes (Acute Care Hospitalization, Emergency Department Use), HHCAHPS measures (Care of Patients, Communication, Specific Care Issues, Overall Rating, Willingness to Recommend). Each HHA's Total Performance Score compared to (a) baseline (own historical performance) and (b) cohort (size-matched peer cohort); achievement score + improvement score combined for Total Performance Score; payment adjustment applied to Medicare base rate.

Star Rating on Care Compare -- CMS publishes two Star Ratings: (a) Quality of Patient Care Star Rating (1-5 stars) based on OASIS + claims-based outcomes, (b) Patient Survey Star Rating (1-5 stars) based on HHCAHPS; publicly displayed on Care Compare driving patient + referral source choice.

The disciplined home health operator: builds OASIS-E + HHCAHPS + claims-based outcome reporting into EMR workflow with automated data capture + automated submission + real-time dashboards, monitors OASIS-E accuracy monthly with corrective action for coding errors + functional/comorbidity coding optimization, monitors HHCAHPS results quarterly with corrective action for low scores (visit-pattern + training + communication improvement), monitors HHVBP Total Performance Score quarterly with corrective action for low measures (especially Improvement in Ambulation + Bathing + Dyspnea + Acute Care Hospitalization + ED Use), incorporates HHVBP performance into QAPI program + clinical staff incentive compensation + Star Rating optimization.

---

📈 PART 4 -- GROWTH & EXIT

Marketing, community education & referral cultivation

Home health marketing is fundamentally B2B-to-referral-sources (hospital discharge planners + SNF/IRF step-down + physicians + ACO/MA + community organizations) plus secondary B2C-to-families-researching-home-health-care. The marketing stack:

(1) Home health liaisons / community liaisons (PRIMARY BD function) -- HHA-employed BD reps embedded with referring hospitals + SNFs + IRFs + physician practices; daily presence + same-day response + clinical capability + 24-48 hour SOC + low rehospitalization scores + responsive communication; 5-15 strong referral relationships drive 40-60% of admits.

(2) Hospital preferred-HHA panel positioning -- large hospital systems (HCA, Tenet, Ascension, CommonSpirit, Trinity, Providence, AdventHealth, Cleveland Clinic, Mayo, Kaiser, Sutter, Banner, Atrium, Northwell) maintain preferred-HHA lists with 3-7 HHAs; quality demonstration + low rehospitalization + Star Rating earn inclusion.

(3) Physician outreach + CME (Continuing Medical Education) -- quarterly CME events for referring physicians on home health eligibility + Medicare benefit + chronic disease management at home + post-acute care coordination.

(4) ACO + MA plan partnerships -- formal partnerships with ACOs + MA plans for preferred-provider arrangements; growing dominant referral pathway as value-based care expands.

(5) Community education + senior services outreach -- community presentations to senior centers + faith communities + civic organizations + Area Agency on Aging on home health services + Medicare benefit + chronic disease management.

(6) Care Compare profile optimization -- HHA profile on medicare.gov/care-compare with Star Rating + Quality measures + HHCAHPS + services + ownership; respond to data accuracy + family reviews.

(7) Website with services + clinical specialties + admissions inquiry form + family resources -- modern home health websites support family decision-making + referral source verification.

(8) Google Business Profile + Maps + Google Ads -- local search for [city] home health / home health near me / Medicare home health [city]; Google Ads $5-$15 CPC.

(9) NAHC + Partnership for Quality Home Healthcare + state home care association -- industry association membership + advocacy + networking + education + benchmarking.

(10) HHVBP performance positioning -- top-quartile HHVBP Total Performance Score = referral source preference + Medicare payment premium.

(11) Reputation management -- Google/Yelp/Facebook reviews + Care Compare quality measures + HHCAHPS patient satisfaction; respond to all reviews professionally; address complaints rapidly.

(12) Specialty positioning -- complex wound care, IV therapy, behavioral health, pediatric home health, perinatal, post-cardiac, post-orthopedic surgery, oncology, dementia/Alzheimer's specialty programs.

Marketing budget: typical HHA runs 2-4% of revenue on marketing ($200K-$720K annually for stabilized 500-census HHA) including home health liaisons (often largest line item at $100K-$210K loaded cost per liaison), CRM/intake software, Google Ads, community engagement, CME events, NAHC membership. Census benchmarks: target stabilized 500-1,000 census for single-office HHA; scaling to 2,500-10,000 census for multi-office regional HHA; 50,000-350,000+ census for multi-state mega platform. Census growth rate: disciplined HHA grows 15-35% census annually in years 1-3 from de novo ramp; 8-15% organic + acquisition growth in mature years.

Scale milestones from 1 office to multi-state platform

Single-office 100-300 census HHA: $2M-$6M revenue, 25-50 FTE (with per-visit therapy contracted), 5-12% EBITDA margin, $100K-$720K EBITDA, founder is hands-on Administrator typically with DPCS + business office; single-office founder profile = manageable regulatory + operational job; lifestyle business or growth platform.

Single-office 300-700 census HHA: $6M-$14M revenue, 45-85 FTE, 8-15% EBITDA margin, $480K-$2.1M EBITDA; sub-acquisition candidate or scaling regional platform foundation.

Multi-office regional 2-5 offices (500-2,500 census): $10M-$50M revenue, 75-300 FTE; founder transitions to regional executive role with office Administrators reporting; shared back-office (HR, accounting, billing, compliance, regulatory affairs, BD, IT, EMR, OASIS-E QA).

Multi-state platform 5-25 offices (2,500-15,000 census): $50M-$300M revenue, 300-1,500 FTE; dedicated regional VPs + Chief Clinical Officer + Chief Compliance Officer + Chief Medical Officer + Chief Financial Officer + dedicated regulatory affairs + audit defense + OASIS-E optimization + HHVBP optimization + Star Rating optimization; strong sub-acquisition candidate for PE-backed national consolidators or strategic acquirers (Optum, Humana CenterWell, AccentCare, Amedisys, BAYADA, Aveanna).

National platform 25-960+ offices (15,000-350,000+ census): $300M-$3B+ revenue, 1,500-30,000 FTE; LHC Group (Optum/UnitedHealth acquired April 2023 for $5.4B, ~300,000+ patients, ~960 locations across 38 states), CenterWell Home Health (Humana NYSE: HUM, ~350,000+ patients, ~750 locations across 38 states, largest US home health by census), Amedisys (NASDAQ: AMED, ~300,000+ patients, ~520 home health locations, Optum acquisition pending FTC review), Encompass/Enhabit (NYSE: EHAB, ~250 home health locations + ~110 hospice locations across 34 states), AccentCare (Advent International, ~245 home health locations), Aveanna (NASDAQ: AVAH, ~340 locations), BAYADA (~390 locations), BrightSpring (NASDAQ: BTSG, ~10,000 service locations), Pennant Group (NASDAQ: PNTG, ~135 locations), Compassus (~250 locations), Elara Caring (~225 locations).

Scaling capital: PE growth equity at platform scale (2+ offices or strategic positioning) including healthcare-focused PE (Audax, Vistria Group, Welsh Carson Anderson & Stowe, Clayton Dubilier & Rice, Carlyle Group, KKR, Apollo, Bain Capital, TPG, Webster Equity Partners, Advent International, TowerBrook, Linden Capital Partners, Avista Capital, Centre Partners, Lee Equity Partners, GTCR); strategic acquirers (Optum/UnitedHealth, Humana CenterWell, Aetna/CVS, AccentCare, Amedisys, BAYADA, Aveanna, BrightSpring, Compassus, Pennant); conventional commercial debt through healthcare lenders (BMO Harris, Capital One Healthcare, Truist Healthcare Banking, KeyBanc, Fifth Third, Regions, MidCap Financial); SBA 7(a) for smaller-scale acquisitions up to $5M; revenue-based financing or factoring for working capital (post-RAP-elimination Medicare cash cycle requires more working capital than pre-2022).

PE/strategic consolidation, Optum dominance & exit math

Exit multiples for home health operating companies in 2025-2026 vary by scale, census, payer mix, EBITDA margin, geographic concentration, audit standing, HHVBP score, Star Rating, and accreditation. Multiples have compressed from pre-Optum-era 8-12x EBITDA range to current 6-10x range as PDGM cuts + behavioral adjustment + HHVBP penalties + RN labor + MA rate compression + Optum-Amedisys FTC scrutiny weigh on the space.

Single-office HHA (100-500 census): typically sells at 5-7x EBITDA depending on census + payer mix + market position + audit history + HHVBP score; 7-9x for stabilized 500+ census with clean audit + 4-5 stars on Care Compare + top-quartile HHVBP; 4-6x for sub-200 census + audit issues + low Star Rating; distressed/under-100 census + audit/CIA + LUPA issues at 3-5x or asset-sale-only.

Multi-office regional HHA (500-2,500 census): 6-9x EBITDA for stabilized regional HHAs with diversified geographic mix + strong quality + balanced payer mix + clean audit. Multi-state platform (2,500-15,000 census): 7-10x EBITDA for top-tier regional operators. National platform (15,000-350,000+ census): 8-12x EBITDA for top-tier brand operators (Optum paid 5.4B for LHC at ~12x EBITDA April 2023 reflecting strategic value of MA + senior services integration vs standalone home health multiple).

Optum/UnitedHealth dominance + Amedisys FTC scrutiny -- Optum acquired LHC Group April 2023 for $5.4B (closed), Optum announced Amedisys acquisition for $3.3B June 2023 (pending FTC review since 2023, FTC + DOJ scrutiny on healthcare consolidation, deal status uncertain through 2024-2026); combined LHC + Amedisys under Optum would represent ~600,000+ annual home health patients + ~$5B+ home health revenue under single insurer integrating Medicare Advantage + home health vertically; antitrust + competition concerns. Humana CenterWell Home Health (formerly Kindred at Home) -- Humana acquired Kindred at Home 2018 + partial divest to Clayton Dubilier + TPG 2022 + reabsorbed 2022 as CenterWell Home Health = ~350,000+ patients, ~750 locations across 38 states, largest US home health by census integrated with Humana Medicare Advantage.

PE consolidators historically active in home health: Advent International (AccentCare 2019), Welsh Carson Anderson & Stowe (Curo legacy, now Humana), Audax Group (Compassus + HouseWorks), Vistria Group, Clayton Dubilier & Rice + TPG (Humana home health partial 2021-2022), Webster Equity Partners (Bristol Hospice), TowerBrook (Compassus), Linden Capital Partners, Avista Capital, Centre Partners, Lee Equity Partners, GTCR, Carlyle Group, KKR, Apollo, Bain Capital, BrightSpring/KKR PE (NASDAQ: BTSG IPO January 2024).

Strategic operating company acquirers: Optum/UnitedHealth (LHC + Amedisys pending), Humana CenterWell, AccentCare, Amedisys (independent until FTC ruling), BAYADA, Aveanna, BrightSpring, Compassus, Pennant, Encompass/Enhabit, regional operators in target geographies.

Exit valuation drivers: (1) Census scale (larger census = higher multiple, 500+ census threshold for serious PE attention, 2,500+ for national PE interest), (2) EBITDA margin (12%+ premium, sub-8% discount, 15%+ rare premium), (3) HHVBP Total Performance Score (top-quartile premium, bottom-quartile discount), (4) Star Rating on Care Compare (4-5 stars premium, 1-2 stars discount), (5) Audit posture + history (clean PEPPER/UPIC/TPE premium, CIA or active audit deep discount), (6) LUPA % (sub-5% premium, 10%+ discount), (7) Payer mix (traditional Medicare-dominant 70%+ premium, MA-heavy discount due to rate compression), (8) Geographic concentration (single-state efficiency premium, multi-state platform premium for national PE interest), (9) Accreditation (CHAP/ACHC/TJC current premium, lapsed/issues discount), (10) Referral source concentration (diversified 5-15 sources premium, 1-2 source concentration discount), (11) CON / moratorium status (CON-state premium for acquired CON moat; moratorium-state premium for acquired provider number), (12) Founder transition (founder willing to roll equity + 2-3 year earn-out premium).

Counter-case & risks

Covered in detail in the dedicated Counter-Case section below: PDGM behavioral adjustment + 2024-2026 cumulative rate cuts 4-7%, OASIS-E complexity + over-coding audit risk, HHVBP nationwide 2023+ with payment adjustments plus/minus 5% by 2025 escalating to plus/minus 9% by 2028, federal CMS moratoriums in FL/IL/MI/TX, 17-state CON barrier (AL/CT/DC/GA/KY/MD/MS/NC/NJ/NY/NV/RI/SC/TN/VT/WV/WA), DOJ qui tam False Claims Act $5B+ recovered 2010-2024 (Amedisys $150M, Kindred/Gentiva $125M+, LHC $65M+, Maxim $150M), RN labor crisis (40-55% turnover + contract agency 2-3x premium), referral source dependency (40-60% from 5-15 sources, losing 1-2 collapses census), hospital readmission penalty effects driving HHA selection, Optum dominance + Amedisys FTC scrutiny + antitrust concerns, MA-side rate compression (60-85% of FFS rates), RAP elimination 2022 lengthening Medicare cash cycle, LUPA payment cliff risk, HHQRP/HHCAHPS reporting burden, Star Rating competitive pressure.

The Operating Journey: From CMS-855A Application To Stabilized Multi-State Home Health Platform

The Decision Matrix: Format Selection And Operating Model

Sources

1. CMS Home Health Center (cms.gov/medicare/medicare-fee-for-service-payment/homehealthpps) -- Dominant CMS home health payment + regulatory data source covering PDGM 30-day payment periods, HHRG case-mix groups, LUPA thresholds, FY2025 base rate, Home Health Quality Reporting Program, Care Compare. https://www.cms.gov/medicare/medicare-fee-for-service-payment/homehealthpps
2. CMS 42 CFR 484 Home Health Conditions of Participation -- Federal regulatory backbone for home health licensing covering patient rights, comprehensive assessment, care planning, QAPI, infection control, skilled professional services, HHA services, personnel qualifications, emergency preparedness, clinical records. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-484
3. CMS Care Compare Home Health (medicare.gov/care-compare) -- Dominant home health quality data source with Star Rating + OASIS + HHCAHPS + claims-based outcome measures, ownership data, contact information. https://www.medicare.gov/care-compare/?providerType=HomeHealth
4. CMS PDGM Patient-Driven Groupings Model -- January 2020 PDGM 30-day payment period model with HHRG case-mix groups, behavioral adjustment, ongoing rate cuts CY2023-2026, LUPA thresholds. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HomeHealthPPS/HH-PDGM
5. CMS OASIS-E Outcome and Assessment Information Set version E -- Effective January 2023 expanding from OASIS-D1 with 100+ assessment items scored at SOC + Recert + Transfer + Discharge driving HHRG payment + HHVBP quality + HHQRP. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HomeHealthQualityInits/OASIS-Data-Sets
6. CMS HHVBP Home Health Value-Based Purchasing -- Nationwide January 2023 with payment adjustments plus/minus 5% by CY2025 escalating to plus/minus 9% by CY2028 based on Total Performance Score across 12 measures. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HHVBP
7. CMS HHQRP Home Health Quality Reporting Program -- Mandatory quality reporting program; failure to report = 2% Medicare payment reduction. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HomeHealthQualityInits
8. CMS HHCAHPS Home Health Consumer Assessment Survey -- Patient experience survey administered by CMS-approved CAHPS vendor (NRC Health, Press Ganey, SHP, Deyta, HEALTHCAREfirst, Fazzi). https://homehealthcahps.org
9. CMS Star Rating on Care Compare -- Quality of Patient Care Star Rating (1-5 stars) + Patient Survey Star Rating publicly displayed driving patient + referral source choice. https://www.medicare.gov/care-compare
10. CMS PEPPER Program for Evaluating Payment Patterns Electronic Report -- TMF Health Quality Institute-prepared comparative analytics report distributed quarterly with home-health-specific outlier indicators. https://www.pepper.cbrpepper.org
11. CMS Review Choice Demonstration (RCD) Home Health -- Illinois 2016 Pre-Claim Review expanded as RCD in IL/OH/NC/FL/TX with three choice options for pre-claim or post-payment review. https://www.cms.gov/research-statistics-data-and-systems/monitoring-programs/medicare-ffs-compliance-programs/review-choice-demonstration/review-choice-demonstration-home-health-services
12. CMS Medicare HHA Enrollment Moratoriums -- Temporary moratoriums on new Medicare HHA enrollments in FL (Miami-Dade + Broward), IL (Chicago), MI (Detroit), TX (Dallas + Houston) beginning 2013 + extended multiple times; verify current status via PECOS + Moratoria Tool. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/MedicareProviderSupEnroll/MoratoriaProviderServicesandPaymentSystem
13. NAHC National Association for Home Care and Hospice -- Dominant home health industry trade association covering ~33,000 home care + hospice providers with policy advocacy, education, regulatory updates. https://www.nahc.org
14. Partnership for Quality Home Healthcare -- Industry coalition advocating for traditional Medicare home health policy, PDGM rate restoration. https://www.homehealth4america.org
15. MedPAC (Medicare Payment Advisory Commission) -- Independent congressional agency advising Congress on Medicare payment with comprehensive home health payment + quality data in annual March + June reports. https://www.medpac.gov
16. LHC Group (Optum/UnitedHealth acquired April 2023 for $5.4B) -- ~300,000+ patients annually, ~960 locations across 38 states, now operates under Optum Home Health umbrella. https://www.lhcgroup.com
17. CenterWell Home Health (Humana NYSE: HUM, formerly Kindred at Home) -- ~350,000+ patients, ~750 locations across 38 states, largest US home health by census. https://www.humana.com/centerwell
18. Amedisys (NASDAQ: AMED) -- ~300,000+ patients annually, ~520 home health locations + hospice + personal care, Optum acquisition pending FTC review since 2023. https://www.amedisys.com
19. Enhabit (NYSE: EHAB) -- Spun off from Encompass Health 2022, ~250 home health + ~110 hospice locations across 34 states. https://www.ehab.com
20. AccentCare (Advent International) -- PE-backed home health + hospice + personal care, ~245 home health locations, acquired Seasons Hospice 2020. https://www.accentcare.com
21. Aveanna Healthcare (NASDAQ: AVAH) -- ~340 locations across 35 states, home health + hospice + private duty + pediatric. https://www.aveanna.com
22. BAYADA Home Health Care -- ~390 locations across 23 states, home health + assistive care + hospice. https://www.bayada.com
23. BrightSpring Health Services (NASDAQ: BTSG) -- IPO January 2024 at $13/share raising $693M, ~10,000 service locations across 50 states, home health + hospice + pharmacy + personal care, KKR PE legacy. https://www.brightspringhealth.com
24. Pennant Group (NASDAQ: PNTG) -- Ensign Group spinoff 2019, ~135 senior living + home health + hospice across 13 states. https://www.pennantgroup.com
25. Compassus -- Audax + TowerBrook PE backed, ~250 locations across 30 states with Ascension Health JV, home health + hospice + palliative + infusion. https://www.compassus.com
26. Elara Caring -- PE-backed, ~225 locations across 17 states, home health + hospice + personal care + behavioral health. https://www.elaracaring.com
27. VNS Health (formerly Visiting Nurse Service of New York) -- Largest US nonprofit home + community health, ~46,000 patients daily across NYC. https://www.vnshealth.org
28. Homecare Homebase (Hearst Health) -- Dominant home health + hospice EMR with ~30%+ market share including LHC, Amedisys, Compassus, Pennant, HouseWorks, BAYADA. https://www.hchb.com
29. MatrixCare Home Health and Hospice (ResMed) -- Major home health EMR (also dominant in SNF), full clinical + financial + quality reporting. https://www.matrixcare.com
30. WellSky Home Health (formerly Kinnser) -- Dominant mid-market home health EMR. https://wellsky.com/home-health
31. Axxess Home Health -- Home health EMR for mid-market with OASIS-E + scheduling + RCM. https://www.axxess.com
32. HHAeXchange -- Largest Medicaid EVV (Electronic Visit Verification) vendor for home health and personal care under 21st Century Cures Act mandate. https://www.hhaexchange.com
33. CHAP (Community Health Accreditation Partner) -- Dominant home health + hospice accreditor with CMS-deemed status. https://www.chapinc.org
34. DOJ Home Health Fraud Enforcement (justice.gov) -- Department of Justice civil + criminal home health fraud prosecution recovered $5B+ 2010-2024 with major cases Amedisys $150M (2014), Kindred/Gentiva $125M+ cumulative, LHC $65M+ cumulative, Maxim $150M (2011). https://www.justice.gov/civil/false-claims-act
35. BLS 29-1141 Registered Nurses (RN) -- Bureau of Labor Statistics wage data showing RN median wage $75K-$110K with home health premium $3K-$10K. https://www.bls.gov/oes/current/oes291141.htm

Numbers

Industry Size And Demand Reality (CMS, NAHC, MedPAC, US Census)

• US Medicare-certified home health agencies: ~11,500 per CMS Home Health Compare
• US Medicare beneficiaries served by home health annually: ~3.2M per NAHC + MedPAC
• US average episodes per beneficiary year: ~5 per CMS claims data
• Top home health diagnoses: ~25% cardiac/circulatory + ~20% musculoskeletal post-surgical + ~15% diabetes/endocrine + ~12% neurological + ~10% wound/infectious + ~8% respiratory + ~10% other
• 75+ population 2024: ~24M growing to ~45M by 2040 per US Census
• 65+ population 2024: ~58M growing to ~80M by 2040
• For-profit home health market share: ~80% in 2024
• Nonprofit home health market share: ~10%
• Government/hospital-based home health market share: ~10%
• Medicare Advantage penetration of Medicare lives: ~50% in 2024 (growing)
• Home health provider scale: small <100 census, mid 100-500, large 500-2,500, mega 2,500+
• LHC Group (Optum 2023, $5.4B): ~300,000+ patients, ~960 locations, 38 states
• CenterWell Home Health (Humana): ~350,000+ patients, ~750 locations, 38 states (largest by census)
• Amedisys (Optum pending): ~300,000+ patients, ~520 home health locations
• Enhabit (NYSE: EHAB): ~250 home health + ~110 hospice locations, 34 states
• AccentCare (Advent): ~245 home health locations
• Aveanna (NASDAQ: AVAH): ~340 locations, 35 states
• BAYADA: ~390 locations, 23 states
• BrightSpring (NASDAQ: BTSG): ~10,000 service locations, 50 states (IPO January 2024 $13/share $693M raise)
• Pennant Group (NASDAQ: PNTG): ~135 locations, 13 states
• Compassus: ~250 locations, 30 states (Audax + TowerBrook + Ascension JV)
• Elara Caring: ~225 locations, 17 states
• VNS Health (NYC nonprofit): ~46,000 patients daily (largest US nonprofit)
• CON states for home health: 17 (AL, CT, DC, GA, KY, MD, MS, NC, NJ, NY, NV, RI, SC, TN, VT, WV, WA)
• Federal CMS HHA enrollment moratorium states (selected metros): FL (Miami-Dade + Broward), IL (Chicago), MI (Detroit), TX (Dallas + Houston)
• RN turnover (home health): 40-55% routinely
• Home health RN wage premium over general RN: $3K-$10K
• 2024+ HHVBP payment adjustment range: plus/minus 5% by CY2025 escalating to plus/minus 9% by CY2028
• HHQRP non-reporting Medicare payment reduction: 2%
• PDGM cumulative rate cuts 2024-2026: 4-7% (CY2023 -3.925%, CY2024 -2.890%, CY2025 -1.975%, CY2026 projected continued)
• DOJ home health FCA recovery 2010-2024: $5B+

Startup Cost Stack By Operator Format

Insurance Stack (Annual Year 1)

Medicare PDGM 30-Day Payment Rates (FY2025)

Payer Mix Reality

Real Estate And Capital Financing Reality

Cost Stack Per Stabilized 500-Census HHA (Mature Year 3, Balanced Payer Mix + LUPA Discipline)

(NOTE: This base case shows compressed ~12% EBITDA margin reflecting PDGM rate cuts + LUPA risk + MA rate compression + visit-based labor intensity. Disciplined operators achieving 12-15% EBITDA run at 500+ census, traditional-Medicare-dominant payer mix, sub-5% LUPA, top-quartile HHVBP, sub-10% agency, balanced PDGM coding accuracy, clean audit posture.)

Per-Format Mature Year 3 P&L Summary (Home Health Agency)

Five-Year Revenue Trajectory By Format

Operational Benchmarks

• Stabilized census target single-office: 300-700 (industry small <100 / mid 100-500 / large 500-2,500)
• Census growth rate de novo years 1-3: 15-35% annually
• Census growth rate mature: 8-15% organic + acquisition
• Target payer mix: 70-85% traditional Medicare PDGM + 10-20% Medicaid + 5-15% MA + 1-5% commercial
• RN case manager ratio: 1:25 (typical industry benchmark)
• RN case manager visits per day: 5-7
• PT/OT visits per day: 6-8
• HHA visits per day: 6-8
• MSW visits per day: 3-4 + phone support
• 30-day payment period average visits per HHRG: 8-15 (varies by clinical group + functional + comorbidity)
• LUPA % target: <5% (industry 7-10%)
• LUPA threshold: ~30 visits per 30-day period (varies 2-6 by HHRG)
• 24-48 hour SOC (start of care) target from referral
• ALOS (admission length of stay) target: 60-120 days (single 60-day cert or up to 2-3 cert renewals)
• Recertification rate target: 50-65%
• Discharge to community target: 75-85%
• Acute Care Hospitalization (HHVBP measure) target: <15% within first 60 days
• Emergency Department Use Without Hospitalization (HHVBP measure) target: <12% within first 60 days
• Star Rating target: 4-5 stars (1-5 scale on Care Compare)
• HHVBP Total Performance Score target: top-quartile cohort
• HHQRP reporting compliance target: 100% (non-reporting = 2% Medicare cut)
• OASIS-E accuracy target: 100% (over-coding triggers audit, under-coding leaves revenue on table)
• RN turnover target: 30-40% (industry 40-55%)
• HHA turnover target: 30-40% (industry 40-60%)
• Contract agency target: <10% of nursing labor (industry urban 10-20%)
• Home health RN wage: $75K-$110K (BLS 29-1141 + premium $3K-$10K)
• Home health PT wage: $80K-$110K (BLS 29-1123)
• Home health OT wage: $80K-$108K (BLS 29-1122)
• Home health SLP wage: $80K-$108K (BLS 29-1127)
• Home health PTA wage: $55K-$78K (BLS 31-2021)
• Home health COTA wage: $55K-$72K (BLS 31-2011)
• Home health LPN wage: $50K-$72K (BLS 29-2061)
• Home health HHA/CNA wage: $32K-$48K (BLS 31-1131)
• Home health MSW wage: $55K-$78K (BLS 21-1022)
• Administrator wage: $95K-$165K (BLS 11-9111)
• DPCS RN wage: $95K-$145K
• Clinical manager wage: $85K-$125K
• OASIS-E QA reviewer/coder wage: $80K-$115K
• Per-visit RN rate: $65-$120/visit
• Per-visit PT/OT/SLP rate: $65-$120/visit
• Per-visit PTA/COTA rate: $40-$70/visit
• Per-visit HHA rate: $25-$45/visit
• Per-visit MSW rate: $65-$100/visit
• Contract agency RN rate: $85-$135/hour (2-3x premium over core)
• Mileage reimbursement: IRS rate ~$0.67/mile CY2025
• Workers Comp NCCI 8826 rate: $2.50-$6.50 per $100 payroll
• Insurance load Year 1 500-census: $200K-$850K
• Marketing budget % of revenue: 2-4%
• Google Ads CPC home health keywords: $5-$15
• DOJ home health FCA recovery 2010-2024: $5B+
• Amedisys DOJ settlement (2014): $150M
• Kindred/Gentiva DOJ cumulative settlements: $125M+
• LHC Group DOJ cumulative settlements: $65M+
• Maxim Healthcare DOJ settlement (2011): $150M
• Almost Family DOJ settlement (2017): $9.4M
• Operating business EBITDA multiple single-office HHA: 5-7x (7-9x for stabilized 500+ census, 4-6x sub-200)
• Operating business EBITDA multiple regional 500-2,500 census: 6-9x
• Operating business EBITDA multiple multi-state 2,500-15,000 census: 7-10x
• Operating business EBITDA multiple national 15,000-350,000+ census: 8-12x
• Optum/LHC acquisition multiple (April 2023, $5.4B): ~12x EBITDA (strategic MA + senior services premium)
• Multiples compression vs pre-Optum era: from 8-12x range down to 6-10x range

Local Regulatory Reality (Top Home Health States)

Exit Multiples By Format

Strategic Acquirers

• Optum / UnitedHealth Group (NYSE: UNH) -- LHC Group acquired April 2023 for $5.4B; Amedisys acquisition pending FTC review since 2023
• Humana CenterWell (NYSE: HUM) -- ~350,000+ patients (formerly Kindred at Home), largest US home health by census
• Amedisys (NASDAQ: AMED) -- ~300,000+ patients (independent until FTC ruling on Optum deal)
• Enhabit (NYSE: EHAB) -- ~250 home health + ~110 hospice locations
• AccentCare (Advent International PE) -- ~245 home health locations
• Aveanna Healthcare (NASDAQ: AVAH) -- ~340 locations
• BAYADA Home Health Care (PE/private) -- ~390 locations
• BrightSpring Health Services (NASDAQ: BTSG) -- IPO January 2024, ~10,000 service locations
• Pennant Group (NASDAQ: PNTG) -- Ensign spinoff ~135 locations
• Compassus (Audax + TowerBrook + Ascension JV) -- ~250 locations
• Elara Caring (PE-backed) -- ~225 locations
• Welsh Carson Anderson & Stowe -- Healthcare PE
• Audax Group -- PE consolidator (Compassus + HouseWorks)
• Vistria Group -- Healthcare PE
• Advent International -- PE sponsor (AccentCare)
• TowerBrook Capital Partners -- PE sponsor (Compassus)
• Clayton Dubilier & Rice (CD&R) -- Humana home health partial 2021-2022
• TPG -- Mega PE
• Webster Equity Partners -- PE sponsor
• Linden Capital Partners -- Healthcare PE
• Avista Capital -- Healthcare PE
• GTCR -- PE
• KKR -- Mega PE (BrightSpring legacy)
• Apollo Global Management -- Mega PE
• Bain Capital -- Mega PE
• Carlyle Group -- Mega PE
• Aetna / CVS Health (NYSE: CVS) -- Strategic insurance integrator
• Ascension Health -- Catholic health system (Compassus JV)
• Trinity Health -- Catholic health system (Trinity Health At Home)

Counter-Case: Why Starting A Home Health Agency Business In 2027 Might Be A Mistake

A serious founder must stress-test the case above against the conditions that make this model a bad bet.

Counter 1 -- PDGM behavioral adjustment + 2024-2026 cumulative rate cuts (4-7%) compress Medicare revenue per episode. CMS implemented Patient-Driven Groupings Model (PDGM) January 2020 replacing the legacy HHPPS 60-day episode model with 30-day payment periods + HHRG case-mix adjustment + behavioral adjustment. The behavioral adjustment assumed agencies would change coding/visit behavior (more institutional-source coding, more early-period coding, more comorbidity coding) to inflate payments; CMS then monitored actual coding behavior + found agencies did adjust upward, triggering ongoing rate clawbacks: negative 3.925% CY2023, negative 2.890% CY2024, negative 1.975% CY2025, with projected continued cuts in CY2026 totaling 4-7% cumulative. NAHC + Partnership for Quality Home Healthcare lobbying CMS + Congress to reverse cuts but partial cuts have stuck. Operators must plan for continued rate pressure and operate at HHRG case-mix optimization + LUPA discipline + HHVBP top-quartile to offset.

Counter 2 -- OASIS-E (effective January 2023) complexity + 100+ assessment items + over-coding audit risk. OASIS-E expanded from OASIS-D1 to 100+ items scored at Start of Care + Resumption of Care + Recertification (every 60 days) + Transfer + Discharge with added items for transfer of health information + social determinants of health + cognitive function + behavioral health screening. OASIS-E drives HHRG case-mix payment + HHVBP quality measures + HHQRP reporting + Star Rating; OASIS-E over-coding is the dominant audit flag -- inflating functional impairment or comorbidity coding to drive up HHRG payment triggers UPIC + TPE + ADR + recoupment + DOJ qui tam exposure. Sophisticated HHAs invest in OASIS-E certification training for all RNs + dedicated OASIS-E QA reviewer (reviewing every OASIS before submission) + ICD-10 certified coders to balance accuracy + revenue optimization. Under-coding leaves revenue on the table = lost margin; over-coding = audit risk + recoupment + reputation damage.

Counter 3 -- HHVBP (Home Health Value-Based Purchasing) nationwide 2023+ with payment adjustments plus/minus 5% by 2025 escalating to plus/minus 9% by 2028. CMS implemented HHVBP nationwide January 2023 after 9-state pilot 2016-2022; payment adjustments plus/minus 5% by CY2025 escalating toward plus/minus 9% by CY2028 based on Total Performance Score across 12 measures: OASIS outcomes (Improvement in Dyspnea, Ambulation, Bathing, Management of Oral Medications, Discharge Function Score) + claims outcomes (Acute Care Hospitalization, ED Use Without Hospitalization) + HHCAHPS measures (Care of Patients, Communication, Specific Care Issues, Overall Rating, Willingness to Recommend). Bottom-quartile HHVBP performers face up to 5% Medicare payment reduction by CY2025 escalating to 9% by CY2028 = potentially 5-9% revenue cut layered on top of PDGM cuts for under-performing agencies. Disciplined operators invest in HHVBP optimization + QAPI + clinical staff incentive compensation + Star Rating optimization.

Counter 4 -- Federal CMS HHA enrollment moratoriums in FL/IL/MI/TX prevent de novo entry in major metros. CMS imposed temporary moratoriums on new Medicare HHA enrollments in Florida (Miami-Dade + Broward), Illinois (Chicago), Michigan (Detroit), and Texas (Dallas + Houston) beginning 2013 + extended multiple times + lifted 2019 + partially reinstated 2020+. In moratorium markets, CHOW (change of ownership) acquisition is the only entry path = acquisition multiples elevated in moratorium markets due to scarcity of active provider numbers. Operators verify current moratorium status via CMS PECOS + Moratoria Tool before applying for de novo enrollment. 17-state CON barrier (AL/CT/DC/GA/KY/MD/MS/NC/NJ/NY/NV/RI/SC/TN/VT/WV/WA) layers additional entry barrier in CON states.

Counter 5 -- DOJ qui tam False Claims Act $5B+ recovered 2010-2024. Major named cases: Amedisys $150M (2014) for OASIS over-coding + therapy over-utilization + ineligible patients, Kindred Healthcare/Gentiva $125M+ cumulative for therapy over-utilization + ineligible patients (Kindred at Home was acquired by Humana 2018 then partial divest 2022 then reabsorbed 2022 as CenterWell Home Health), LHC Group $65M+ cumulative (LHC acquired by Optum/UnitedHealth April 2023), Maxim Healthcare Services $150M (2011) for over-billing, Almost Family $9.4M (2017), plus dozens of smaller settlements $2M-$50M range + ongoing qui tam (whistleblower) FCA cases filed by former employees + nurses + therapists under seal with potential 15-30% relator share driving plaintiff bar interest. Federal audit apparatus: UPIC + ZPIC + TPE + RAC + RCD (Review Choice Demonstration in IL/OH/NC/FL/TX) + OIG + DOJ + HEAT strike forces (Miami/Houston/Detroit/LA/Brooklyn/Tampa/Chicago/Dallas) + qui tam FCA. Single qui tam case can produce $5M-$150M+ DOJ settlement + Corporate Integrity Agreement (CIA) + Medicare termination + reputation damage.

Counter 6 -- RN labor crisis + 40-55% turnover + contract agency 2-3x premium. Home health RN turnover routinely 40-55% with contract agency RN/PT/OT/HHA at $85-$135/hour vs $75K-$110K core wage (2-3x premium). Agency use varies by market (urban tight markets 10-20%, mid-market 5-10%, rural 2-5%). Visit-based labor intensity (RN 5-7 visits/day, PT/OT 6-8 visits/day, HHA 6-8 visits/day) + windshield time + mileage reimbursement ($0.67/mile IRS CY2025) + per-visit pay ($65-$120/visit RN, $25-$45 HHA) all create wage pressure. Competing senior care demand for RNs (hospice + SNF + AL + hospital + clinic + Medicare Advantage care management) keeps wage inflation high. Disciplined operators focus on RN pipeline + retention (sign-on bonuses $5K-$15K, retention bonuses $2K-$10K, predictable visit-based scheduling, home health premium $3K-$10K, career ladder to OASIS-E coder + clinical manager + DPCS, productivity bonuses) to reduce turnover toward 30-40% (still high but better than 55%+).

Counter 7 -- Referral source dependency creates concentration risk. 40-60% of home health admissions flow through 5-15 referral sources (hospital discharge planners + case managers + hospitalists + SNF/IRF social workers + community physicians + ACO networks + MA plan case managers). Losing 1-2 major referral sources can collapse census within 30-60 days -- particularly devastating when a competing HHA wins a hospital preferred-HHA panel position or ACO contract. Large hospital systems (HCA, Tenet, Ascension, CommonSpirit, Trinity Health, Providence, AdventHealth, Cleveland Clinic, Mayo Clinic, Kaiser Permanente, Sutter, Banner, Atrium, Northwell) maintain preferred-HHA lists with 3-7 HHAs = competitive contract + quality demonstration + low rehospitalization scores earn inclusion. Disciplined HHAs diversify referral pipeline + cultivate 15-30 active referral sources + invest heavily in home health liaisons + maintain 24-48 hour SOC capability + clinical excellence demonstrable via Star Rating + HHVBP performance + responsive same-day service to reduce concentration risk.

Counter 8 -- Hospital Readmission Reduction Program (HRRP) effects drive HHA selection. CMS HRRP penalizes hospitals up to 3% of Medicare Part A payment for excess 30-day all-cause readmissions; hospital discharge planners increasingly select HHAs with low rehospitalization scores to reduce HRRP exposure = quality + Star Rating + HHVBP performance directly drive referral share. HHAs with high Acute Care Hospitalization rate (HHVBP measure) + high ED Use rate face structural referral pipeline penalty from hospital discharge planners.

Counter 9 -- Optum/UnitedHealth dominance + Amedisys FTC scrutiny + antitrust concerns. Optum acquired LHC Group April 2023 for $5.4B (closed), Optum announced Amedisys acquisition for $3.3B June 2023 (pending FTC review since 2023, FTC + DOJ scrutiny on healthcare consolidation, deal status uncertain through 2024-2026); combined LHC + Amedisys under Optum would represent ~600,000+ annual home health patients + ~$5B+ home health revenue under single insurer integrating Medicare Advantage + home health vertically = antitrust + competition concerns. Humana CenterWell Home Health (formerly Kindred at Home) has ~350,000+ patients integrated with Humana Medicare Advantage. Vertical integration of insurance + home health creates structural disadvantage for independent HHAs competing for MA referrals from Optum/Humana networks; independents face MA prior auth friction + rate compression while vertically-integrated HHAs receive preferred MA referrals.

Counter 10 -- Medicare Advantage rate compression + prior authorization friction. ~50% of Medicare lives now MA with growth continuing; MA plans pay home health agencies 60-85% of traditional Medicare PDGM rates with prior authorization + visit limits + utilization management + delayed payment. Some MA plans contract via percent-of-PDGM (60-85%) others via per-visit rates ($95-$165/visit) others via capitation. MA-side rate compression is dominant margin pressure as MA penetration grows; operators with MA-heavy payer mix face structural margin disadvantage vs traditional-Medicare-dominant operators. Disciplined operators negotiate MA contracts carefully + target 70-85% traditional Medicare payer mix to preserve margin.

Counter 11 -- RAP elimination 2022 lengthened Medicare cash cycle + LUPA payment cliff risk. CMS eliminated RAP (Request for Anticipated Payment) in 2022 -- RAPs historically provided 50-60% early cash within first week of SOC but CMS eliminated to combat fraud, replacing with NOA (Notice of Admission) within 5 days of SOC (1/30 daily payment reduction for late NOA) with final claim filed at end of each 30-day payment period = 30-60 day Medicare cash cycle vs pre-2022 RAP early cash. Working capital requirement increased post-RAP-elimination = operators need more cash on hand for payroll + vendor payments. LUPA payment cliff -- episodes with fewer than LUPA threshold visits (~3-4 visits typical) per 30-day period paid per-visit ($185-$285/visit by discipline) rather than full HHRG case-mix episode payment = 30-60% revenue drop. Disciplined operators monitor LUPA risk in real-time + adjust visit patterns to push episodes above threshold (without unnecessary visits); industry-average LUPA % 7-10%, target <5%.

Counter 12 -- Adjacent senior care + post-acute formats may fit better for founders attracted to senior services but not Medicare home health regulatory intensity. Non-medical home care / private duty (q9630 adjacent -- no Medicare, lower regulation, lower lawsuit exposure, ~$32-$45/hour private pay or Medicaid HCBS waiver); Hospice (q9656 -- Medicare Hospice Benefit per-diem, IDT, ~$215/day RHC baseline, healthier margins ~15-22% vs home health 8-15%); Palliative care (q9620 -- non-terminal symptom management billed Part B physician fees, less per-diem audit risk, growing as upstream bridge to hospice); SNF (q9655 -- residential 24/7 RN, much higher capital + regulation but Medicare Part A short-stay profit); Assisted living AL (q9650 -- state-licensed senior residential, private pay $4,800-$8,500/month, no Medicare cert, lighter regulation); Memory care MC (q9653 -- dementia-specialized AL); Adult day care ADC (q9652 -- daytime program $85-$185/day); PACE (Program of All-Inclusive Care for the Elderly -- Medicare/Medicaid integrated capitated for nursing-home-eligible at home, growing format); Home infusion therapy (IV antibiotic, TPN, chemotherapy at home -- Option Care Health, CVS Coram, BriovaRx, BioScrip); DME (durable medical equipment) home delivery (hospital bed, oxygen, CPAP -- Apria, Lincare, AdaptHealth, Rotech); Home dialysis (peritoneal + home hemodialysis) -- DaVita HomeFlex, Fresenius Kidney Care; Telehealth + Remote Patient Monitoring (RPM) -- adjacent virtual care delivery; Geriatric care management (RN-led care coordination, fee-for-service, no Medicare); Senior placement agency (A Place for Mom franchise) -- referral services; Hospital-at-home (CMS Acute Hospital Care at Home waiver) -- emerging acute care at home format. For founders attracted to home-based healthcare with growth potential the question reroutes to non-medical home care, hospice, palliative care, PACE, home infusion, RPM, geriatric care management which share demographic tailwind but with different regulatory + audit + reimbursement profiles.

The honest verdict. Starting a home health agency business in 2027 is a reasonable choice for a founder who: (a) has matched capital to format ($165K-$465K de novo non-CON non-moratorium, $465K-$1.4M de novo CON-state, $1.4M-$7M CHOW acquisition required in FL/IL/MI/TX moratorium markets, $5M-$50M multi-office PE-backed rollup, $235K-$685K + system commitment for health-system JV); (b) has secured CMS PECOS + Moratoria Tool verification (FL/IL/MI/TX moratorium status), CON approval (in 17 CON states) or chosen non-CON state, state DOH home health license, CMS-855A Medicare HHA provider enrollment, CHAP/ACHC/TJC accreditation, initial CMS certification survey after first patient validating 42 CFR 484 CoP compliance, HIPAA + 42 CFR Part 2 compliance, healthcare regulatory counsel before opening; (c) has built professional liability + GL $1M/$3M minimum (preferably $2M/$5M-$3M/$10M), Workers Comp NCCI 8826, non-owned auto, property, cyber, EPLI, umbrella $5M-$25M, sexual abuse sub-limit, crime, D&O, pollution, bond/surety insurance stack at $200K-$850K annual for single 500-census HHA; (d) has chosen sub-market with adequate Medicare beneficiary density (25K-65K Medicare beneficiaries in 30-45 minute drive radius), hospital + SNF + IRF discharge volume (3-8 acute care hospitals + 15-30 SNFs + 1-3 IRFs), competitive home health landscape analysis via CMS Care Compare + state DOH HHA list, state CON status + CMS moratorium status, state Medicaid HCBS waiver + Medicaid managed care environment, labor market viability, MA penetration; (e) has built referral pipeline (5-15 active referral sources cultivated via home health liaisons / community liaisons with daily presence + same-day response + clinical capability + 24-48 hour SOC + low rehospitalization scores), clinician staffing per 42 CFR 484 CoP (Administrator + DPCS RN + Clinical Manager + RN case managers 1:25 + LPN/LVN + PT/OT/SLP + PTA/COTA + HHA/CNA + MSW + OASIS-E QA reviewer + intake RN + biller), OASIS-E + ICD-10 + HHRG case-mix optimization discipline, audit-ready compliance posture (UPIC + TPE + RCD + LUPA monitoring + PEPPER quarterly review + HHVBP optimization + Star Rating + OASIS-E QA + ICD-10 audit + OIG exclusion list screening + whistleblower hotline), HHQRP/OASIS-E/HHCAHPS/HHVBP reporting capability automated via EMR, LUPA discipline (target <5% LUPA %), HHVBP top-quartile Total Performance Score discipline, Star Rating 4-5 stars on Care Compare discipline, RN pipeline + retention reducing turnover from 55%+ toward 30-40%, contract agency reduction to under 10%, plaintiff lawsuit defense + specialized home health defense counsel + insurance carrier relationships; (f) has 18-30 months operating reserve to absorb pre-stabilization burn at 100-500 census ramp with 12-30 month stabilization (longer than hospice due to PDGM cash cycle + RAP elimination), and explicit PDGM rate cut + HHVBP + Optum/MA rate compression monitoring discipline as highest operating priority. It is a poor choice for anyone underestimating PDGM rate cuts (4-7% cumulative 2024-2026 + ongoing), anyone underestimating OASIS-E complexity + over-coding audit risk, anyone treating it as a "growing demographic tailwind business" rather than highly-regulated Medicare-dependent visit-based clinical operating business with HHVBP penalty exposure, anyone unwilling to invest in OASIS-E QA + ICD-10 coding + HHVBP optimization + LUPA discipline, anyone underinvested in home health liaison + referral source cultivation, anyone ignoring HHVBP + Star Rating quality measures, anyone undercapitalized for the 12-30 month de novo certification + census ramp + RAP-elimination working capital requirement, anyone unable to navigate dual federal CMS + state DOH + accreditation regulatory complexity + CON + CMS moratorium + RCD process, anyone whose target state is moratorium-restricted (FL/IL/MI/TX) without acquisition capital, anyone with MA-heavy payer mix expectation without margin compression contingency, and anyone whose real interest would be better served by non-medical home care / hospice / palliative care / PACE / home infusion / RPM / geriatric care management adjacent formats. The model is not a scam, but it is more PDGM-rate-cut-exposed, more OASIS-E-complexity-burdened, more HHVBP-penalty-targeted, more LUPA-payment-cliff-risked, more FL/IL/MI/TX-moratorium-blocked, more Optum-dominance-pressured, more MA-rate-compression-squeezed, more referral-source-dependent, more RN-labor-pressured, and more pre-stabilization-fragile than its "aging-in-place demographic tailwind" surface suggests -- and in 2027 the gap between the disciplined version that works and the OASIS-E-naive, LUPA-careless, HHVBP-unoptimized version that fails is wide.

Related Pulse Library Entries

• q1127
• q1139
• q1942
• q1946
• q1947
• q1948
• q1949
• q1951
• q1952
• q1953
• q1954
• q1962
• q1965
• q1966
• q1975
• q2117
• q9576
• q9601
• q9620
• q9628
• q9629
• q9630
• q9650
• q9652
• q9653
• q9655
• q9656